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CHAPTER 1. GENERAL INTRODUCTION 
Leptospirosis, a disease caused by bacteria of the genus Leptospira, occurs in a wide 
range of mammalian hosts worldwide, including human beings. Exposure usually occurs 
after leptospires are excreted in the urine of an infected maintenance host that 
asymptomatically harbors bacteria in its kidneys. Infection can result from direct contact 
with infectious blood or urine or indirect contact with soil or water contaminated with 
infectious urine. Slaughterhouse workers, swine producers, and dairy workers are at risk of 
occupational exposure, and recently, infections have been documented as a result of changing 
modes of human interaction with the environment including outdoor leisure activities, water 
sports, and adventure tourism. In some urban areas, the risk of infection to humans and 
companion animals has increased due to increased numbers of reservoirs. 
After entering the body through mucous membrane contact or abraded skin, bacteria 
replicate in the bloodstream or organs. The onset of clinical signs occurs in 3 to 20 days. 
Signs are initially non-specific and include lethargy, anorexia, fever, and myalgia. Signs 
may progress to include vomiting, diarrhea, bleeding tendencies, icterus, and death. 
Exposure to leptospires results in a humoral immune response to the dominant leptospiral 
antigen, lipopolysaccharide (LPS). An adequate antibody response clears bacteria from the 
bloodstream and abates clinical signs. However, antibodies do not reach leptospires harbored 
in the renal tubules, so leptospires may be shed in the urine. In this manner, the cycle of 
disease continues allowing another animal to be infected. 
Canine leptospirosis has been known since 1899. Historically, the most common 
causes of canine leptospirosis have been Leptospira interrogans serovars 
Icterohaemorrhagiae and Canicola. Vaccines have been available for these serovars and the 
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incidence of disease has decreased. Since 1983, the incidence of leptospirosis in dogs has 
significantly increased and has been associated with different serovars. Serological data and 
bacterial isolation suggests that Leptospira kirschneri serovar Grippotyphosa and Leptospira 
interrogans serovars Pomona and Bratislava are now the most common causes of 
leptospirosis in dogs. Until recently, vaccines were not available for protection against these 
serovars, and serovar Bratislava still is not included in commercially available canine 
vaccines in the United States. 
Study of these emerging serovars is necessary to allow for the development of new 
prevention strategies and treatment regimens. Case reports and retrospective studies have 
provided some information on serovars Grippotyphosa, Pomona, and Bratislava, but 
complete experimental studies have not been done. Experimental studies provide 
information on clinical signs, biochemical and hematologic abnormalities, and course of 
disease that benefits practicing veterinarians. In addition, the development of a regimen that 
can be used to test various leptospiral isolates is critical to rigorous testing of prevention and 
treatment protocols in an organized, repeatable way. The objectives of the experiments 
described in this dissertation were to: 1) use a model of canine leptospirosis to describe the 
clinical and pathologic abnormalities caused by infection with Leptospira interrogans 
serovars Pomona and Bratislava and Leptospira kirschneri serovar Grippotyphosa, 2) 
characterize hemorrhagic lesions in a guinea pig model of Leptospira interrogans serovar 
Pomona infection, and 3) test the hypothesis that leptospires bind platelets in vitro. 
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Dissertation Organization 
This dissertation is organized to include one chapter containing a manuscript 
submitted for publication and two additional chapters containing manuscripts prepared for 
publication. These chapters follow the General Introduction and Literature Review. The 
first manuscript, "Clinical and pathologic comparison of acute canine leptospirosis caused by 
two strains of Leptospira kirschneri serovar Grippotyphosa" relates the clinicopathologic 
abnormalities and the lesions caused by these bacteria. The second manuscript, 
"Experimental canine leptospirosis caused by Leptospira interrogans serovars Pomona and 
Bratislava" describes the features of disease in dogs caused by these two emerging serovars. 
The third manuscript, "Leptospira interrogans serovar Pomona infection in guinea pigs and 
in vitro evidence of leptospire binding of platelets" demonstrates that Leptospira interrogans 
serovar Pomona causes hemorrhages in guinea pigs and provides support for the hypothesis 
that leptospires interact directly with platelets. The final chapter contains a General 
Discussion of this work. 
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Literature Review 
Leptospirosis and Leptospira 
Leptospirosis, one of the most widespread zoonotic diseases,1 is a reemerging disease 
of dogs2 and humans,3,4 especially those living in urban centers.5 The clinical syndrome of 
leptospiral infection was first described in 1886,6 and the causative agent of leptospirosis 
(Weil's disease) described in 1915.7 Severe infections can cause pulmonary, renal, and 
hepatic failure. Leptospirosis can affect virtually all warm-blooded animals8 and leptospires 
have been isolated from reptiles, amphibians, fish, birds, and invertebrates throughout the 
world.5 
Environment and culture 
Leptospires survive in warm, moist environments in neutral to slightly alkaline pH, and 
are able to retain their pathogenicity outside the host for as long as six months,9'10 but 
replication occurs only inside the host in natural conditions." Saprophytic leptospires are able 
to grow at much lower temperatures.12 Chlorine, sea water, acidic pH and drying destroy 
leptospires.13 Leptospires can be grown in aerobic culture, and the most common media 
contain Tween as a carbon source and ammonium salts as a source of nitrogen.12,14 Leptospires 
do not synthesize fatty acids, but rather degrade them by ^ -oxidation.'5 Leptospire resistance to 
5-fluorouracil is exploited to reduce the growth of contaminants in culture.16 
Nomenclature 
Spirochetes were first described in 1833, and today the order Spirochaetales contains 
the families Leptospiraceae and Spirochaetaceae, which contain Leptospira, Leptonema, 
Turneria; and Brachyspira, Treponema, and Borrelia, respectively.9 New isolates of 
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Leptospira continue to be discovered and the nomenclature has changed to keep up with 
more modern genetic means of differentiating these isolates. Previously, pathogenic 
leptospires were recognized as one species, Leptospira interrogans, with saprophytic strains 
classified as Leptospira biflexa. Although serovar distinctions are still used, genetic analysis 
has resulted in division of the genus Leptospira into at least 17 species under which over 268 
serovars are categorized.17 Serovar distinctions are the result of serologic categorization of 
isolates based on an agglutination reaction to homologous antiserum, due to slightly different 
epitopes in the outer membrane lipopolysaccharide.18 
Morphology 
Leptospires are aerobic spirochetes measuring 0.1 [im wide and 6-20 fim long with 
hooked ends. Contained within a fluid outer membrane are a helical cell cylinder and two 
periplasmic flagella. The outer membrane is approximately 11 nm wide 19 and is composed 
of 3 to 5 electron-dense layers.20'21 The inner protoplasmic cylinder contains two circular 
chromosomes of approximately 4500 kb and 350 kb, respectively.22,23 The flagella reside 
within the periplasmic space, are attached near the terminus of the protoplasmic cylinder, and 
extend toward the center of the bacterium which help maintain cell shape and allow for 
motility.24 
Structurally, leptospires share characteristics with gram-negative bacteria. 
Spirochetes and gram-negative bacteria have a lipopolysaccharide (LPS) dominated outer 
membrane that serves as a permeability barrier, protecting them from harsh environmental 
conditions. 
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Virulence attributes 
Attachment 
To be effective pathogens most bacteria use specific mechanisms to adhere to host 
cells.25 Attachment properties may be related to virulence as virulent leptospires have greater 
attachment to the extracellular matrix proteins fibronectin,26 collagen, and laminin than 
avirulent lines.27,28 Leptospires attach to cultured epithelial cells,29 fibroblasts,30 endothelial 
cells,31 and macrophages.32 Immunogold labeling suggests an initial interaction with cell 
surface membranes of hepatocytes, renal tubular epithelium, and renal interstitial 
endothelium before internalization and cell damage occur.33 Leptospires adhere to 
phagocytes in the absence of specific antibodies by binding the CR3 integrin 
(CD1 lb/CD 18).34 Leptospiral immunoglobulin-like (Lig) proteins localized on the bacterial 
surface comprise one mechanism of host cell attachment.35 
Motility 
Motility is conferred by rotation of the periplasmic flagellum within the periplasmic 
space generating a spiral-shaped wave in the outer membrane sheath while the protoplasmic 
cylinder rolls around the flagella in the opposite direction.24 This corkscrew motility allows 
movement in viscous environments36 at a greater velocity than low-viscosity media,24 and 
may aid in colonization of environments where the immune system is less efficient (i.e. eye).9 
Leptospires can penetrate tight junctions in endothelial and epithelial cell cultures, and can be 
seen free within the cytoplasm,37'38 within vesicles,31,39and within erythrocytes.39 Motility 
alone, or in conjunction with other factors, may allow for the rapid translocation of cell 
monolayers described in vitro.ss 
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Toxins 
Few organisms may be present in areas with lesions, which may be the result of toxic 
factors released from the spirochete or host.40,41,42,43 Toxic factors of leptospires include 
LPS,44 glycolipoprotein,45 peptidoglycan,46 and phospho lipases.47,48 
The LPS is embedded in the outer membrane,37 and comprises the major surface 
component. However, it does not cause endotoxic effects.49 Despite some structural, 
biochemical, and immunological similarities to gram-negative LPS, leptospiral LPS is 10 
fold less toxic for animals or cells.50 When procedures for endotoxin isolation from gram-
negative bacteria were applied to virulent Leptospira interrogans serovar 
Icterohaemorrhagiae, injections of the extract into animals failed to produce clinical signs.51 
One aspect of this markedly different response may be a result of leptospiral LPS ligand 
specificity for Toll-like receptor-2 (TLR2) rather than TLR4 like gram-negative bacteria.52 
Glycolipoprotein adheres to endothelial cells and epithelial membranes, is colocalized 
with antigen derived from degenerating bacteria,40 and is associated with endocytosis.53 The 
lipid portion of the leptospiral glycolipoprotein causes membrane perforation, cellular 
leakage, and cell death.45 One mechanism of injury is through inhibition of the Na,K 
ATPase.54, 55, 56 Application of Leptospira derived Na, K ATPase antagonists to peripheral 
blood mononuclear cells (PBMC) results in cytokine secretion.43 
Leptospiral peptidoglycan causes proliferation of human peripheral blood 
mononuclear cells, stimulates phagocytosis, induces the metabolic burst of resting and 
phagocytosing leukocytes,57 and induces release of TNF-a from human monocytes.46 
Pathogenic strains of Leptospira contain enzymes with hemolytic activity such as 
sphingomyelinase C58 and phospholipases.47,59 Sphingomyelinase C destroys erythrocyte cell 
8 
membranes leading to hemolysis,60 which may liberate iron and fatty acids.9 SphH, a 
homo log to the sphingomyelinase C of L. borgpetersenii causes hemolysis through pore 
formation.61 Some strains of Leptospira exhibit positive chemotaxis to hemoglobin,62 but the 
recent demonstration of a pathway for the biosynthesis of heme63 may suggest that hemolysis 
is more likely a means of obtaining fatty acids. 
Outer membrane proteins (OMPs). OMPs consist of transmembrane proteins and outer 
membrane lipoproteins that are anchored to either the extracellular or the periplasmic side of 
the membrane. Lipoproteins, the most abundant proteins in spirochete outer membranes, 
play a role in host immunity and inflammation.64'65 Leptospires, unlike typical gram-
negative species, have a paucity of outer membrane proteins, which may be a mechanism of 
avoiding the host immune response.66 However, the scarcity of OMP's implies that those 
present are critical to function. A few have been characterized in detail including a porin, 
OmpLl,67,66 two lipoproteins, LipL3668 and LipL41,69 and the major outer membrane protein 
(MOMP) LipL32.70 OmpLl, LipL41, and LipL32 are present in natural infections based on 
immunohistochemistry and immunoblot evidence.64 OmpLl is conserved among pathogenic 
species and is surface located. However, it is expressed at very low levels and is difficult to 
purify due to its association with LPS.66 
Some OMPs exhibit the potential for immunoprotection, and all pathogenic 
Leptospira express transmembrane proteins that are less variable than serovar specific LPS. 
These may be useful in preparing improved vaccines.64 Immunization with OmpLl, an 
integral outer membrane porin,66 and LipL41, a lipoprotein, are protective when administered 
in concert.64 LipL32 is the most prominent protein in the leptospiral protein profile, is 
expressed during in vitro and in vivo, and is conserved among pathogenic species.70 The 
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abundance of LipL32 in the outer membrane may also make it useful as a serologic 
diagnostic test, since humans have been shown to have a stronger antibody response to this 
lipoprotein than other outer membrane proteins based on ELISA absorbance.70,71 
In vitro cultivation is associated with qualitative and quantitative changes in LPS and 
OMPs,72 For example, LipL36 is expressed in cultured Leptospira kirschneri serovar 
Grippotyphosa, but is downregulated during mammalian infection.68 LipL45, an inner 
membrane protein, is expressed by many low passage strains of serovar Grippotyphosa, but 
not in high passage strains.73 
Pathogenesis 
The concepts of maintenance and incidental hosts are critical to understanding the 
pathogenesis of leptospirosis. There are different clinical implications due to infections with 
host-adapted and non-host-adapted species of Leptospira .74 Maintenance or reservoir hosts 
serve as a source of infection, and infection persists in these animals without causing severe 
clinical signs. Rodents such as the wild Norway rat and albino laboratory rat are 
nonsymptomatic carriers of some serovars of Leptospira,75 but depending on the serovar of 
Leptospira, many different species can serve as reservoirs. Typically, maintenance hosts do 
not show clinical signs, have a low serologic response, and fail to clear the organism from the 
kidneys. These hosts serve as long term source of infection because they excrete leptospires 
in their urine. Transmission between maintenance hosts is efficient. When outbreaks occur 
with host-adapted strains, it is a result of exposure of immunologically naïve animals.74 
In incidental hosts, disease onset is acute and severe leading to organ failure and 
death. Often there are high titers of agglutinating antibody, and a short renal carrier state.2 
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Human beings are usually an incidental host that becomes infected through occupational or 
environmental exposure.76 Incidental hosts are not important reservoirs, but direct 
transmission through alternative routes such as human to human transmission through breast 
milk have been described.8,77 
Modes of transmission are direct including venereal, transplacental, conjunctival, or oral 
exposure, or indirect contact with contaminated water or soil or indirect vectors.10 
Leptospires enter the blood stream by epithelial invasion at the mucous membranes or entry 
through abraded skin after direct contact with infected urine or indirect contact with 
contaminated water. During a variable incubation period (3-20 days) leptospires circulate in 
the blood and replicate in the liver, spleen, kidneys, eyes, and other tissues. The length of the 
incubation period depends on the virulence, infecting dose, and the susceptibility of the 
host.10 Agglutinating antibodies appear soon after leptospires are in the bloodstream and are 
associated with clearance of the leptospires from the blood. Nonspecific clinical signs are 
reported including fever, inappetence, vomiting, abdominal pain, diarrhea, 
polyuria/polydipsia, myalgia, jaundice, epistaxis, hematuria, and reproductive failure, but 
subclinical infections are common.78'79 It is not clear if clinical signs occur as a result of 
damage caused by large numbers of leptospires circulating in the blood, or due to leptospiral 
toxins such as lipopolysaccharide or glycolipoprotein.45 
Renal colonization is requisite for shedding of organisms in the urine. Interstitial nephritis 
and tubular necrosis occur as a result of leptospire migration in the interstitium, renal tubules, 
and tubular lumina80 likely compounded by liberation of toxin,81 renal ischemia,82 and 
immunologic reaction.83 The primary path of leptospires from the blood into the renal 
tubules is between proximal convoluted tubular epithelial cells and is associated with early 
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interstitial edema followed by the presence of leptospires between cells.84 In a hamster 
model of serovar Bataviae infection, lesions were detectable at 6 hours PI, and leptospires 
were detected within the proximal tubules at 9 hours PI.80 Mild and transient glomerular 
involvement after initial infection has been described and is associated with C3 trapping in 
glomerular tufts.80 Leptospires remain in kidney and eye for weeks or months after infection. 
Serovars Studied 
Serovars common to temperate climates include Icterohaemorrhagiae, Hardjo, 
Pomona, Bratislava, and Canicola, while additional serovars are common to the tropics.4 
Traditionally, serovars Icterohaemorrhagiae and Canicola are the most prevalent in dogs, but 
recent clinical and epidemiologic evidence suggests that other serovars are more prevalent in 
canine populations in the U.S. and Canada including Leptospira kirschneri serovar 
Grippotyphosa and Leptospira interrogans serovars Pomona and Bratislava85"87 for which 
dogs serve as incidental hosts. 
Serovar Grippotyphosa 
Serovar Grippotyphosa is commonly isolated from wild mammal carriers such as 
squirrels, opossums, foxes, raccoons, and skunks.2,88'89 L. kirschneri serovar Grippotyphosa 
has been associated with severe, rapid onset renal and hepatic failure in dogs, and in the 
Midwest,87 Georgia,88, and New York,90 is the predominant serovar responsible for canine 
leptospirosis. 
Serovar Pomona 
Serovar Pomona infections in swine cause abortion, stillbirths, and neonatal deaths,90' 
91 and has been isolated from cattle, horses, humans, sheep, and wildlife.92 Swine,76'90'92 
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deer,74 skunks, and opossums92 serve as a reservoir of serovar pomona infection, but the field 
vole (Microtus lagrestis) and raccoons are thought to be the most common reservoirs in the 
United States.88 Pomona was demonstrated to be the cause of clinical illness and death in sea 
lions from the coast of California after contacting contaminated surface water while on 
land.93 The serovar Pomona isolate used in our studies is Leptospira interrogans serovar 
Pomona type kennewicki.94'95 
Serovar Bratislava 
Leptospira interrogans serovar Bratislava has been isolated from North American and 
European swine with reproductive failure,96 and has been isolated from stillborn and neonatal 
swine97 and tissues from slaughter.98 There is a high seroprevalence of serovar Bratislava in 
North American horses, a presumed reservoir.74 There is serologic evidence of infections in 
dogs, 79,99 but serovar Bratislava has rarely been isolated.79,96 
Animal models 
A suitable system for the biological measurement of virulence attributes of a 
leptospiral isolate requires animals susceptible to the strains of leptospires being tested. It is 
difficult to study leptospirosis in laboratory mice and rats because they rapidly develop high 
agglutinating antibody titers after exposure to leptospires.75'100 Clinical signs only occur in 
rats inoculated after cyclophosphamide immunosuppression of humoral immunity.75 Suitable 
susceptible species that have been used as laboratory animal models of leptospiral disease 
include hamsters (Cricetus aureus, Cricetus sinensis), guinea pigs (Cavia cobaya), and 
gerbils (Meriones unguiculatus, M. shawi, M. crassus sacramenti). Young guinea pigs33'l01' 
13 
102 and hamsters41,70, l03,104 are used in experimental studies and to test and maintain virulence 
of leptospires.105 
Canine Leptospirosis 
The clinical entity that came to be known as canine leptospirosis was first described 
in 1899.106 Leptospirosis should be considered as a differential diagnosis for dogs presenting 
with pulmonary signs, renal disease, hepatic disease, or a combination of all three.85 The 
recognition of disease clinically is less frequent than the predicted prevalence by serologic 
studies.90 It has been suggested that the incidence of disease may be higher than predicted by 
serology since infections may occur from serovars not tested in the serologic panel,107 and 
because clinically normal dogs may shed leptospires and lack clinical signs to warrant 
testing.108 
In the United States, canine leptospirosis has traditionally been associated with 
Leptospira interrogans serovars Canicola and Icterohaemorrhagiae. Retrospective and 
experimental studies have extensively documented the lesions and biochemical abnormalities 
associated with disease caused by serovar Canicola83, 106'l09'110 and serovar 
Icterohaemorrhagiae.111-114 The use of vaccines containing these serovars has markedly 
reduced the incidence of leptospirosis in dogs.99,115 However, those vaccines do not induce 
cross-protective antibody to serovars not contained in the vaccine.2 The diagnosis of 
leptospirosis has increased at North American veterinary teaching hospitals since 1983.86 
Several factors may be playing a role in the increased detection of leptospirosis in dogs, 
including increased prevalence of the disease due to the emergence of new serovars, changes in 
diagnostic procedures and awareness, or changes in vaccine usage.86 
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Leptospirosis caused by Leptospira kirschneri serovar Grippotyphosa78'll6'117 and L. 
interrogans serovars Pomona78'U5'118 and Bratislava79, 96'99 have emerged as an important renal 
and hepatic disease of dogs in North America2,78,85,99 and the United Kingdom.119 Serovars 
Grippotyphosa and Pomona are reported to be the most seroprevalent.120 The increased 
prevalence of these new serovars in dogs may be a result of entering a niche previously filled 
by serovars Canicola and Icterohaemorrhagiae or increasing opportunities for contact with 
maintenance hosts in suburban areas.2 In the northern United States, there is an increased 
incidence in dogs from August to November when temperatures are optimal for 
environmental survival.85 Unusually wet conditions also can cause a marked rise in case 
numbers over a short period of time.121 Preliminary experimental studies were done with 
serovar Grippotyphosa, but few dogs were used and inoculation was by an unnatural route 
(subcutaneous or intravenous).88 Serovar Grippotyphosa has been implicated as the cause of 
acute renal failure88 and chronic active hepatitis,116 and serovar Pomona was isolated from a 
dog with jaundice and hepatic insufficiency.118 
These emerging serovars are a national concern because there has been an increase in 
diagnosis, vaccines have not been available that protect against the new serovars and because 
of the potential for zoonotic transmission.122 The importance of improving control of 
leptospirosis in dogs is underscored by the fact that infections with serovar 
Icterohaemorrhagiae, the most commonly diagnosed serovar of Leptospira in humans,118 is 
associated with exposure to infected dogs,74 and immunized dogs have been documented as a 
source of zoonotic infection.123,124 More commonly, however, human beings come into 
contact with urine contaminated soil or water or are infected through occupational exposure 
with increased risk to farmers, sewer workers, miners, fisherman, and slaughterhouse 
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workers." In addition, new ways of interacting with the environment such as ecotourism 
and outdoor sports have been the source of infection in recent human outbreaks.4' "'l25'126 
Other serovars have been studied in dogs after experimental infection127 or accidental 
infection in laboratory beagles.128'129 Experimental infection caused by serovar Bataviae 
caused severe, but variable disease with hepatic, renal, and hemorrhagic manifestations.127 
Accidental infection of laboratory beagles with serovar Saxkoebing was clinically 
inapparent, but acute hepatic and renal abnormalities with multiple hemorrhages resulted 
from infection with another serogroup Sejroe pathogen in that population of dogs.128 An 
earlier report of accidental infection of laboratory beagles with serovar Sejroe described 
clinically inapparent infections with 59% of the dogs had interstitial nephritis and titers of 
1:100 to 1:6400 without any prior indication of infection when necropsied at the end of a 
toxicology study.129 In some areas, there is a high seroprevalence of serovar Autumnalis, but 
isolation and identification was not done making it unclear if serovar Autumnalis is present 
in dogs or if the titers are a result of serologic cross-reactivity.'2' 
Host response 
Immunology. Leptospires interact with the host on many levels. After entering the 
bloodstream, virulent leptospires are rapidly phagocytosed by fixed phagocytes.130 
Leptospiral entry into macrophage cell lines can induce apoptosis, but entry into renal 
fibroblast (Vero) cell lines does not result in apoptosis.131 Apoptosis of hepatocytes, 
however, is induced early in disease when leptospires are localized between and not within 
hepatocytes, which may facilitate further colonization. The role apoptosis plays in allowing 
further colonization of tissues requires more study. 
Plasma cytokine levels are elevated in severe leptospirosis,43 which are similar to 
classical endotoxin mediated bacterial sepsis of gram-negative organisms. Elevated acute 
tumor necrosis factor alpha (TNF-A) levels parallel the severity of disease, whereas 
interleukin-10 (IL-10) levels are elevated, but not associated with the severity of disease.43 
Glycolipoprotein extracted from pathogenic leptospires, but not saprophytic leptospires was 
demonstrated to activate human peripheral blood mononuclear cells.43 These cells secreted 
TNF-A and IL-10 and had a concommitant increase in expression of CD69 and HLA-DR, 
markers for cellular activation.43 When outer membrane protein extracts are applied to 
cultured medullary thick ascending limb of loop of Henle (mTAL) cells, nuclear DNA 
binding of the NFkB transcription factor is induced132 indicating activation of inflammatory 
responses. 
Resistance to leptospiral infection has been shown to be primarily humorally 
mediated through experimental inoculations of mice and rats with cyclophosphamide, a 
selective blocker of humoral immunity.75'100 Treated rats had longer leptospiremic phases, 
higher replication rates, and greater tissue invasion than nontreated rats, which occurred 
during a period of absence of agglutinating antibodies relative to control rats.75 In guinea 
pigs, increased resistance to infection was correlated with increased weight of the guinea 
pigs, the development of the ability to produce agglutinating antibodies, and with maturation 
of B-cell dependent areas of lymphoid tissue.102 Lipopolysaccharide is recognized as an 
important antigen in immunity,37'133'134 and the antigenic determinants of leptospiral LPS are 
carbohydrate.134'133 Recent bovine studies demonstrate a potent cellular immune response 
characterized by production of IFN-y by yô T lymphocytes after vaccination.135'136 A 
preference toward 7Ô T lymphocytes also occurs in human peripheral blood mononuclear 
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cells when exposed to high numbers of leptospires, whereas a(3 T cell expansion occurs when 
exposed to low numbers of leptospires.137 
Vaccination. Reduction of exposure and immunization are critical for prevention of 
leptospirosis.4 A traditional vaccine for leptospirosis has been available for decades and 
contains two serovars that have been most commonly associated with disease in dogs: 
Leptospira interrogans serovars Canicola and Icterohaemorrhagiae. The predominant 
immunologic reaction occurs to lipopolysaccharide (LPS) in the outer membrane of the 
bacteria. Immunity to leptospires is serovar specific due to differences in the LPS. Whole-
cell-killed bacterins and membrane sheath preparations have been shown to be equally 
protective, but sheath preparations are associated with fewer adverse reactions.19 Since the 
immune response is serovar specific, production of bacterins with traditional techniques 
requires adding more serovars of bacteria to the injected product. Although this seems to be 
effective, it also increases the possibility of adverse reactions due to leptospiral LPS or 
proteins in the culture media. In addition, this type of vaccine provides only short-term 
protection.91 Dogs vaccinated with currently available vaccines with expanded serovar 
coverage and challenged with serovar Canicola are protected from clinical signs, but may 
still shed bacteria in their urine138'139 for long periods of time.123 
Histopathology. Due to the critical role of the kidney in the lifecycle of leptospire 
infection and excretion renal lesions are frequent. Plasma cells within interstitial infiltrates 
are associated with anti-leptospiral but not anti-renal tubular antibodies.83 By 
immunohistochemistry, leptospiral antigen can be demonstrated in intact organisms within 
the proximal convoluted tubules, granular deposits within macrophage cytoplasm, and as 
clumps within the interstitium.83'140 Severity and extension of lesions of the renal 
microvasculature occur in parallel with tubular lesions suggesting the simultaneous action of 
a toxin on both101 with exacerbation of tubular lesions by hypoxia.141 Interstitial nephritis 
and edema are prominent in infected animals with and without renal insufficiency suggesting 
that additional factors play a role in renal failure.101 A mixed cell infiltrate generally 
indicates more acute disease,142 and functions in antibody production and phagocytosis.83 
Despite severe clinicopathologic abnormalities, infected dogs with serovars Autumnalis and 
Canicola did not have major histopathologic changes.110 
Ultrastructure. Ultrastructural studies demonstrate lesions directly associated with 
the presence of leptospires and lesions not spatially associated with organisms. Serovar 
Icterohaemorrhagiae infection in guinea pigs causes intracellular edema, dilated ER, 
edematous microvilli, and mitochondrial changes including enlargement, clearing of the 
matrix, and abnormal christae.101 In infected animals, leptospires are visible in vascular and 
tubular lumina; intercellular spaces; and in one occasion, within an intact tubular cell.101 
More typically, only fragments of leptospires are present within lysosomes of the tubular 
epithelial cells.84 
Serum biochemical abnormalities. Renal and hepatic damage are commonly 
reported in leptospirosis. Serum biochemical alterations are indicative of renal tubular injury 
leading to potassium secretion probably due to a decrease in proximal sodium reabsorption 
with collecting duct resistance partially responsible for the inability to concentrate urine.1 
Glucosuria occurs in some cases, likely as the result of tubular damage.78 Increased urinary 
excretion of low molecular weight proteins results from tubular damage in leptospirosis.143 
Hematology, hemostasia and platelets. The most common hematologic 
abnormalities are mature neutrophilic leukocytosis, mild non-regenerative anemia, and 
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thrombocytopenia.85,99 Hemorrhage is a common clinical sign in human beings and animals 
with leptospirosis, but the role of platelets in the mechanism of hemorrhage in leptospirosis 
has not been well characterized. Platelets are small, anuclear cells that circulate in the blood 
and function in maintaining vessel integrity by forming a platelet plug during endothelial 
injury. Decreased numbers of circulating platelets and altered platelet function may both 
play a role in the development of clinical hemorrhage. Platelet aggregation at sites of 
vascular injury is essential for the formation of the primary hemostatic plug and also for the 
development of thrombi. The initial contact of the platelet with the injured vessel wall 
(platelet adhesion) involves multiple adhesive substrates (von Willebrand factor, collagen) 
and receptors on the platelet surface (GPIb/V/IX, integrins ocubPa and «2(31). Physiologic 
platelet agonists (ADP, collagen, thrombin) work by increasing the number or ligand 
efficiency of adhesion receptors.144 Injury to the vessel wall exposes collagen fibers in the 
subendothelium, which activates platelets to form a plug to prevent loss of blood. At this 
point, the platelets change shape and come into contact with other platelets. Granule contents 
are secreted and contraction occurs allowing the aggregated mass to plug the damaged site 
and limit blood loss. 
Thrombocytopenia78'8S' l21'145 and pulmonary hemorrhage are common 
manifestations of leptospirosis in humans.146"149 However, hemorrhagic disease also occurs in 
the absence of thrombocyopenia.147 Low numbers of circulating platelets may result from a 
lack of production, increased destruction, or loss. The hypothesis that thrombocytopenia and 
widespread endothelial damage are the cause of disseminated intravascular coagulopathy 
(DIG) and hemorrhage in patients with leptospirosis is no longer accepted.145,148,150 Slightly 
elevated fibrin degradation products (FDP) were considered evidence for DIG in one study,80 
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but the occurrence of DIC has not been substantiated by other experimental studies. In one 
case, high titers of surface bound Ig and response to corticosteroids suggested an immune 
mediated pathogenesis of thrombocytopenia.145 Inflammation of the vessel wall induced by 
leptospiral toxins has been proposed as a cause for low platelet counts in the previous 
studies,"1 but was not demonstrated or specifically investigated. Vasculitis affects primarily 
the capillaries of "filter" organs such as kidney, liver, and lung." Endothelial cells 
participate in inflammatory responses through expression of adhesion molecules and the 
production of cytokines.152 If platelets are functioning properly, normal hemostatic 
mechanisms are maintained even after platelet counts fall well below the normal reference 
range. 
A leptospire interaction with normal integrin allbft function could have severe 
consequences to normal hemostasis. Integrin cdlbjSg complexes mediate platelet aggregation 
by binding fibrinogen or vWF (von Willebrand factor), protein cofactors that form bridges 
between adjacent platelets.153 The cross linked adhesive proteins assemble platelets into an 
aggregate. Binding of vWF and other adhesive proteins, such as fibronectin, to integrin 
allbjSs is mediated by the Arg-Gly-Asp (RGD) sequence, a universal mediator of cellular 
interactions with the extracellular matrix. GPIIb-IIIa inhibitors block aggregation and 
"outside in" signaling, which would lead to other events such as secretion, clot retraction, 
and procoagulant activity. 
Platelet to spirochete binding is a feature of other diseases caused by spirochetes 
including relapsing fever154 and Lyme disease.155'156 In relapsing fever, the pathogen, Borrelia 
hermsii, alters the conformation of integrin allbp3 on resting platelets resulting in contact-
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dependent activation.154 Borrelia burgdorferi, the causative agent of Lyme disease, binds 
with greater affinity to activated platelets.155 Spirochete to platelet binding in Lyme disease is 
directly associated with the ability to cause disease, i.e. those spirochetes unable to bind 
platelets do not cause clinical signs in animal models.155 
Diagnosis 
Clinical diagnosis of leptospirosis can be challenging because signs are nonspecific. 
Nonspecific clinical signs of leptospirosis including fever, inappetence, vomiting, abdominal 
pain, diarrhea, polyuria/polydipsia, myalgia, jaundice, epistaxis, and hematuria may suggest 
disease, but are not diagnostic. Clinical pathologic changes can be variable depending on 
stage of infection. Diagnosis is most often initially based on clinical suspicion and confirmed 
later by laboratory methods.157 There is no sensitive, specific, low-cost, rapid and widely 
available diagnostic test for leptospirosis,11 so multiple methods of diagnosis must be used. 
Serologic tests include the microscopic agglutination test (MAT)91'158'159 and enzyme-linked 
immunosorbent assay.160 Diagnosis is made by a fourfold increase in paired serum samples or 
a single markedly elevated titer.87 The titer of the infecting serovar predominates,161 but 
multiple titers can develop during the first six weeks of clinical disease.85 Serology is 
complicated by antibody cross-reactivity between different serovars and the presence of low-
titers during acute disease.78'88'99 Leptospiruria in the absence of MAT titers is not unusual.79 
Previously vaccinated dogs may have elevated titers that further complicate diagnosis, and 
some dogs may become infected and actively shed organisms without ever having a titer 
greater than 1:100.79 Dogs treated early may not develop MAT titers greater than 1:100162 or 
may seroconvert to negative after appropriate treatment.163 In addition, MAT titers may not 
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reliably reflect the immune status against leptospiral infections.164 The MAT measures 
primarily IgM.87 IgM immunoglobulins often occur within the first week of infection and 
commonly reach a peak level by the second week,120 but IgM and IgG titers can be 
demonstrated by ELIS A in instances when the agglutination titer by MAT remains low.165 It 
is advisable to confirm any positive results obtained using a commercial screening test by 
submitting samples to a specialized reference laboratory.157 
Immunofluorescence testing,166 dark field microscopy, culture, polymerase-chain-
reaction assays, and histopathology with special stains (e.g. silver) can be used to identify 
leptospires in the tissues or body fluids of dogs. However, there are drawbacks to each of these 
diagnostic tests. A major disadvantage to dark-field microscopy and immunofluorescence 
testing is the inability to identify the infecting serovar.159 Darkfield microscopy is an excellent 
screening tool for urine, but is of low sensitivity, and organism shedding can be 
intermittent.99,118 Culture is the diagnostic gold standard, but leptospires are difficult to culture, 
may take many months to grow, and cultures are susceptible to contamination. PCR assays can 
be specific and sensitive, but are not widely available99,163 The DNA from as few as 100 
leptospires can be isolated, amplified, and detected,167 but it may not be possible differentiate 
the causative serovar.168 Silver stain is the traditional method for demonstration of spirochetes 
in tissue sections.169 However, difficulties arise when using silver stains because of extensive 
reticulin staining and inability to recognize leptospiral fragments, especially if few organisms 
are present. Leptospires can be difficult to demonstrate in cases confirmed positive by other 
diagnostic methods, and silver stains cannot identify altered leptospires, leptospire fragments, 
or antigenic products.170 Immunohistochemical methods have improved the ease with which 
antigen can be demonstrated in paraffin embedded tissues,41'140'170 but may not be an 
23 
appropriate procedure for clinical cases because biopsy of severely affected organ systems 
would be required. 
Summary 
The most common serovars of Leptospira associated with disease in dogs have 
changed to include Leptospira kirschneri serovar Grippotyphosa and Leptospira interrogans 
serovars Pomona and Bratislava. Data from clinical cases most commonly indicate renal and 
hepatic damage, but the specific clinical and pathologic manifestations caused by these 
emerging serovars have not been investigated in an experimental setting. Developing 
improved treatment and prevention techniques for this widespread zoonotic disease requires 
further study to better understand the course of clinical disease, biochemical abnormalities, 
and lesions caused by serovars Grippotyphosa, Pomona, and Bratislava. 
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ABSTRACT 
Objective—The purpose of this experiment was to develop a model of acute canine 
leptospirosis caused by Leptospira kirschneri serovar Grippotyphosa. 
Animals—31 nine-week-old, female beagle dogs. 
Procedure—Beagles were randomly assigned to challenge or control groups. Challenge 
groups were inoculated on three successive days by conjunctival instillation of 5xl07 cells of 
either Leptospira kirschneri serovar Grippotyphosa strain 82 (n-12) or serovar 
Grippotyphosa strain RM 52 (n=14); control dogs (n=5) were similarly inoculated with 
sterile leptospiral culture media. Clinical signs, clinical pathological parameters, anti-
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leptospiral antibody titers, and presence of leptospires in tissues and body fluids were 
evaluated after challenge. Dogs were euthanized and necropsies were done on days 7,14, 
22, and 28 post-inoculation or as required because of severe illness. 
Results— In dogs infected with serovar Grippotyphosa, clinical signs included 
conjunctivitis, lethargy, diarrhea, dehydration, vomiting, and icterus. Consistent clinical 
pathologic alterations included azotemia, hyperphosphatemia, increased anion gap, 
hyperbilirubinemia, and increased alkaline phosphatase. Leptospires were cultured from 
kidney (11/12), urine (6/9), aqueous humor (9/12), blood (12/12), and liver (12/12) of dogs 
inoculated with serovar Grippotyphosa strain 82. Only three dogs became infected with 
serovar Grippotyphosa strain RM52. Histologic lesions in infected dogs included interstitial 
nephritis, renal tubular degeneration and necrosis, pulmonary hemorrhage, and hepatic 
edema and perivasculitis. 
Conclusions and Clinical Relevance—Conjunctival exposure to L. kirschneri serovar 
Grippotyphosa strain 82 resulted in acute leptospirosis in all inoculated dogs, but only 3/14 
(21%) of RM52 inoculated dogs became acutely ill. A model of infection by L. kirschneri 
serovar Grippotyphosa is described and will be used to further explore the pathogenesis and 
prevention of canine leptospirosis. 
Key words: Leptospira, kidneys, hepatic disease, clinical pathology-general, zoonotic 
disease 
INTRODUCTION 
Leptospirosis, one of the most widespread zoonoses, is a re-emerging disease of dogs.1 
The diagnosis of canine leptospirosis in the United States and Canada significantly increased 
between 1983 and 1998.2 In the United States, leptospirosis in dogs has traditionally been 
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associated with Leptospira interrogans serovars Canicola and Icterohaemorrhagiae. 
Experimental disease caused by serovars Canicola and Icterohaemorrhagiae has been 
described,3"10 and the use of vaccines containing these serovars has markedly reduced the 
incidence of disease caused by them.3'4 Until recently, vaccines have been available to 
protect against only those serovars. In the past 10 years, increasing numbers of cases of 
canine leptospirosis have been described with isolation or serologic evidence to support the 
involvement of L. kirschneri serovar Grippotyphosa and L. interrogans serovars Bratislava 
and Pomona.x'2'3 Features of disease caused by these serovars such as time course, lesions, 
and biochemical abnormalities that may be serovar specific have not been well identified 
because of the paucity of experimental studies and the inability to determine the time of 
exposure in clinical cases. 
Literature concerning experimental investigation of the course of disease, lesions, and 
confirmation of infection by serovars Grippotyphosa, Bratislava, and Pomona in dogs is 
sparse5'6 despite the emergence of these serovars as important causes of renal and hepatic 
disease of dogs in North America. ''3,7,8 To better understand the progression of clinical 
signs and clinicopathologic abnormalities in the course of disease with these emerging 
serovars, experimental studies are needed. The purpose of this study was to inoculate dogs 
with L. kirschneri serovar Grippotyphosa under controlled conditions and document clinical 
signs, changes in CBC and biochemistry profiles, and gross and histopathologic lesions at 
necropsy. 
MATERIALS AND METHODS 
Dogs—All animal experiments were approved by the Iowa State University 
Committee on Animal Care. Thirty-one nine-week-old purpose-bred female beagle pups that 
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lacked detectable antibodies to serovar Grippotyphosa by the microscopic agglutination test9 
were used. For the duration of the experiment, animals were housed two per cage in 
temperature-controlled rooms in the Iowa State University BL-2 Animal Holding Facility. 
Separate rooms were used for control, strain RM52 inoculated, and strain 82 inoculated dogs, 
respectively. Dogs were fed a high quality commercial dry ration. Food and water were 
available at all times and freshened twice daily. Complete blood counts (CBC), serum 
biochemistry panels, and urinalyses were performed on each dog during the acclimation 
period. No abnormalities were noted. The dogs were observed for clinical signs and body 
temperatures were recorded twice daily throughout the experiment. 
Leptospira strains—Two strains of L. kirschneri serovar Grippotyphosa were used. 
Serovar Grippotyphosa strain RM52 was isolated at the USDA/ARS-National Animal 
Disease Center from tissues submitted to the Veterinary Diagnostic Laboratory at Iowa State 
University during an outbreak of swine abortion in 1983.10'11 To enhance virulence 
attributes, leptospires were passaged through hamsters'2 and reisolated. Hamsters were 
housed at the National Animal Disease Center. Intraperitoneal inoculations of consisted of 
106 organisms. Inoculum was cultured in 80/40 semisolid media14 from liver homogenate of 
a hamster with clinical signs. Serovar Grippotyphosa strain 82 was isolated at the National 
Animal Disease Center from the urine of a dog that presented to the Veterinary Teaching 
Hospital at Iowa State University in 1992 with polyuria and polydipsia as the presenting 
complaint. This dog had mild azotemia, hypercalcemia, isosthenuria (SG-1.008), a titer of 
1:1600 for serovar Grippotyphosa, and detection of leptospires in urine by 
immunofluorescence. Hamster passage also was done for this isolate. Inoculum was 
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prepared from cultured liver homogenate from a hamster with clinical signs after 
intraperitoneal inoculation with 106 strain 82 organisms. 
Experimental design—All inoculations occurred via conjunctival instillation. The 
inoculum consisted of 5 x 107 leptospires in 500 jal of 80/40 semisolid leptospiral culture 
medium.13 Two hundred fifty jal was placed onto the corneal surface of each eye of each dog 
and allowed to run onto the conjunctiva. This procedure was repeated once daily for three 
days. Dogs 1-5 served as controls and were inoculated with an equal volume of sterile culture 
media. Dogs 6-17 were inoculated with serovar Grippotyphosa strain 82. Dogs 18-31 were 
inoculated with serovar Grippotyphosa strain RM52. Inoculum was prepared as previously 
described.10 
Necropsy and sample collection— Blood samples for complete blood counts and 
biochemistry profiles including sodium, potassium, chloride, total CO2 (TCO2), calcium, 
phosphorus, blood urea nitrogen, creatinine, glucose, total protein, albumin, alanine 
aminotransferase(ALT), alkaline phosphatase (ALP), y-glutamyltransferase (GGT), creatine 
kinase (CK), direct bilirubin (Dbili), total bilirubin (Tbili), and anion gap were taken pre-
inoculation and scheduled for days 7,14,22, and 28 post-inoculation. If animals were 
necropsied on alternate days, appropriate samples were collected at that time. Necropsy 
values of serum biochemical assays of infected dogs were compared to baseline values using 
a paired T-test. 
Euthanasia and necropsies were scheduled for days 7, 14, 22, and 28 post-inoculation 
(PI). Dogs were euthanatized immediately if dogs were assessed as greater than 5% 
dehydrated, exhibited epistaxis, were anorectic, anuric, or febrile for more than 24 hours, or 
had episodes of vomiting or diarrhea that did not resolve within 24 hours. Prior to necropsy, 
38 
dogs were injected with furosemide8 to increase urine production to enhance the probability 
of being able to collect urine for leptospiral culture.13 After euthanasia with an overdose of 
sodium pentobarbital,b liver, kidney, and urine samples were collected aseptically for culture 
and immunofluorescence testing. Samples of kidney, liver, lung, hepatic lymph node, 
adrenal gland, spleen, heart, tonsil, mesenteric lymph node, pancreas, stomach, jejunum, 
vulva, bladder, bone marrow, iliac lymph node, colon, ileum, and cecum were placed in 10% 
neutral buffered formalin, and samples of eye and conjunctiva were placed in Bouin's 
solution. 
Histopathology—Formalin-fixed tissues for histologic evaluation were processed by 
standard paraffin embedding techniques after 24 hours. Sections were cut at 5 jam except 
kidney, lymph nodes, and adrenal gland, which were cut at 3 |im. All sections were stained 
with hematoxylin and eosin. Histopathologic grading of selected lesions of liver, kidney, and 
pancreas was done using no change (-), mild (+), moderate (++), and severe (+++) 
designations. For interstitial nephritis, tubular mineralization, and hepatic perivascular 
infiltrates the scores were assigned as follows: (-) = no change from control dogs, (+) =1-3 
foci/section examined, (++) =4-6 foci/section examined, (+++) = (>6 foci/section examined). 
Tubular degeneration was graded (+) when scattered cells were noted with pyknotic nuclei or 
loss of polarity, (++) when these changes were present in larger sections of a tubule, and 
(+++) when multiple tubules in an area were affected. Tubular dilation was scored (+) when 
scattered tubular lumens were markedly widened and lined by a thin layer of epithelium, (++) 
when multiple tubules were affected, and (+++) when the cortex was diffusely affected. 
Hepatocyte individualization was scored (+) when hepatocyte cell margins where more 
distinct than controls, (++) when there were small clusters or groups of hepatocytes without 
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connections to adjacent cells, and (+++) when this change was present in large sheets of 
cells. Pancreatitis was (+) when small numbers of inflammatory cells were present between 
lobules, (++) when there was infiltration of the lobules by inflammatory cells, and (+++) for 
diffuse inflammation throughout the pancreas. 
Bacteriologic culture—Blood cultures were performed on post-inoculation days 6, 8, 
10, 12, 14, 22, and 28. Liver and kidney samples of approximately 1 gram and aqueous 
humor and urine samples of 1 ml were obtained at necropsy and processed for isolation of 
leptospires. Three media were used to increase the likelihood of isolating leptospires. First, 
Tween 80/Tween 40/lactalbumin hydrolysate was used as previously described14 with slight 
modifications: 5-fluorouracil15 was used at a rate of 100|ig/ml and naladixic acid was not 
used. Second, Ellinghausen-McCullough-Johnson-Harris (EMJH) semisolid media was used 
as previously described 16 with 1% BSA, 100 p.g/ml 5-fluorouracil0 and 1% rabbit serum. 
Finally, commercial Polysorbate Leptospira Medium 5d was used with the addition of 
purified agar® and 100|ag/ml 5-fluorouracil. Cultures were incubated at 29° C for 6 months. 
Darkfield exam was performed at 1,2, 4, 6, and 8 weeks and at 3, 4, 5, and 6 months. If 
cultures became contaminated, approximately 1 ml was filtered through a 0.22 jam filter into 
new medium. Representative isolates were identified by restriction endonuclease analysis of 
chromosomal DNA.17 
Serologic examination—Blood was obtained from dogs 6 days prior to inoculation 
and at days 7, 14, 22, and 28 post-inoculation. Prior to inoculation (Day 0), all dogs were 
free from agglutinating antibodies to serovar Grippotyphosa by the Microscopic 
Agglutination Test (MAT). 9 Blood was collected from seven strain 82 inoculated dogs, 
nine strain RM 52 inoculated dogs, and four control dogs at necropsy for serology. 
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Immunofluorescence test—Samples of urine, kidney, aqueous humor, and liver 
were stained with fluorescein-labeled rabbit anti-leptospiral conjugate as previously 
described.18 Leptospires were identified by typical size, morphology, and fluorescence when 
examined by incident light fluorescence microscopy. 
Immunohistochemistry—Immunohistochemical staining was done on a subset of 
animals to determine the patterns of antigen distribution after infection was confirmed by 
positive culture or immunofluorescence. A monoclonal mouse antibody with reactivity 
demonstrated specific to Leptospira kirschneri serovar Grippotyphosa was used as previously 
described with some modifications. 10,19 Briefly, 5 pim sections were cut, placed on positively 
charged slides, and deparafinized with xylene and ethanol by standard procedures. Slide 
mounted tissue sections were rinsed in potassium phosphate buffered solution (KPBS; 0.15 
M NaCl, 0.034 M K2HPO4, 0.017 M KH2PO4, pH 7.4), and antigen retrieval was performed 
by incubating slides for 7 minutes in 37 C KPBS with 0.1% trypsin and 0.1% CaCh. After 2 
rinses in KPBS, endogenous peroxidase activity was eliminated by a 30 minute incubation in 
0.3% hydrogen peroxide solution in KPBS. The sections were then incubated for two hours 
in blocking solution (KPBS with 1% bovine serum albumin/ 0.4% Triton X-1008, and 1.5% 
normal blocking serum,h and incubated overnight at room temperature (24°C) in primary 
antiserum. On the following day, tissue sections were rinsed in KPBS with 0.2% Triton X-
100 and incubated in an appropriate biotinylated secondary antibody for two hours at room 
temperature, rinsed, and incubated in Horseradish Peroxidase-Avidin-Biotin Complex1 for 1 
hour at room temperature. Enzyme reactions were developed with a substrate kit' producing 
a red reaction. The reaction was terminated in successive rinses of 0.9% NaCl solution. 
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Slides were counterstained with hematoxylin, dehydrated through graded alcohols, and 
coverslipped. 
RESULTS 
Clinical signs and microbiology—A dog was considered infected if leptospires were 
detected in tissues or body fluids by culture, immunofluorescence, or immunohistochemistry 
(see Table 1). Culture and immunofluorescence test results were negative in all control dogs 
(5/5; 100%). Serovar Grippotyphosa was detected in 3 of 14 (21%) RM52 inoculated dogs 
and in all (12/12; 100%) strain 82 inoculated dogs (see Table I). No blood cultures were 
positive on day 5 PI, but all were positive on day 7 PL The 3 dogs without positive urine 
culture or immunofluorescence test were necropsied on day 7 PL Mild reddening of the 
Table 1- Summarized results of bacterial culture and immunofluorescence (FA) testing 
expressed as number of positive results obtained/number of animals tested per group. 
Blood Kidney Liver Urine Aq. Humor Kidney FA Liver FA UrineFA 
Control 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 
Strain 82 12/12 11/12 12/12 6/9* 9/12 10/12 8/12 5/9* 
RM52 3/14 3/14 3/14 1/14 1/14 2/14 2/14 0/14 
* samples unavailable from 3 dogs \ 
sclera and conjunctiva occurred in all leptospire-inoculated dogs on day 1 PI (the second 
inoculation day). On day 5 PI, inoculated dogs were lethargic, and one dog from each of 
serovar Grippotyphosa inoculated groups had more severe reddening of the sclera and 
conjunctivitis with thick ocular discharge. On day 8 PI, two dogs inoculated with strain 82 
were febrile (40.1 C and 40 C, respectively). A third dog was febrile (39.4 C) on day 9 PL 
Clinical signs that indicated euthanasia and necropsy should be performed prior to the 
scheduled date were lethargy, dehydration, depression, subnormal temperature, 
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conjunctivitis, and icterus. Necropsy was done prior to the scheduled date for a total of 11 
dogs: on day 9 PI (n=l; strain 82 group), day 10 PI (n=2; strain 82 group), day 12 PI (n=2 
strain RM52 group; n=5 strain 82 group), and day 13 PI (n=l; strain RM 52 group). 
Remaining strain RM 52 inoculated dogs were necropsied on post-inoculation days 14 (n=3), 
22 (n=4), and 28 (n=5). 
Clinical signs prior to necropsy were similar between strain RM 52 and strain 82 
infected dogs, but a greater percentage of strain 82 dogs showed clinical signs. Clinical 
assessments of dogs revealed groups of inoculated dogs were affected by dehydration [strain 
RM52 ( 2/14), strain 82 (7/12)], icterus [strain RM52 ( 2/14), strain 82 (9/12)], lethargy 
[strain RM52 ( 2/14 ), strain 82 ( 6/12)], coughing [strain RM52( 1/14 ), strain 82 (1/12)], 
diarrhea [strain RM52 (3/14), strain 82 (6/12)], and vomiting [strain RM52 (2/14 ), strain 82 
(5/12)]. 
Necropsy—Gross findings on external examination included icterus, conjunctivitis, 
and ocular discharge. At necropsy, lesions were found in the kidneys, liver, and lungs (Table 
2). Lesions on post-mortem examination were similar for all dogs necropsied on days 9, 10, 
11, and 12 and included icterus of the sclera, gingiva, and subcutaneous tissue; friable, pale 
liver with enhanced lobular pattern; subcutaneous and retroperitoneal edema; multifocal 
petechiae in the lungs; prominent reddened lymph nodes (hepatic and/or internal iliac); and 
enlarged kidneys with perirenal edema. Typically, stomach and intestinal contents were 
scant. One strain 82 inoculated dog that was vomiting had a 10 cm ileocecal intussusception 
with devitalized ileum. 
Histopathology and immunohistochemistry—Lesions of liver, kidney, and 
pancreas are reported (see table 2). Lesions in the liver included mixed perivascular 
Figure 1- Photomicrograph of a section of liver obtained from a L. kirschneri serovar 
Grippotyphosa strain 82 inoculated dog (Dog 6) at 7 days PI. The portal area is infiltrated by 
small numbers of lymphocytes, plasma cells, and fewer neutrophils that surround the hepatic 
vein, lymphatic, and bile duct. H&E stain. Bar = 40 /mi. 
Figure 2- Photomicrograph of a section of liver obtained from a strain 82 inoculated dog 
(Dog 9) at 9 days PL The hepatocytes are individualized and the cytoplasm contains multiple 
small, clear vacuoles (lipid). H&E stain. Bar = 40 /mi. 
Figure 3- Photomicrograph of a section of liver from a strain 82 inoculated dog at 12 days PL 
Mitoses are frequent in sections obtained from infected dogs. The hepatocytes also contain 
lipid vacuoles. H&E stain. Bar = 40 /mi. 
Figure 4- Photomicrograph of a section of kidney from a strain 82 inoculated dog (Dog 6) at 
7 days PL There is slight expansion of the interstitium by infiltrates of lymphocytes, plasma 
cells, and fewer neutrophils. H&E stain. Bar = 40 jum. 
Figure 5- Photomicrograph of a section of kidney from a strain 82 inoculated dog (Dog 15) at 
12 days PL The interstitium is expanded by edema fluid, free erythrocytes, and 
inflammatory infiltrates. There are multifocal dilated proximal convoluted tubules with thin 
epithelium. H&E stain. Bar =140 /mi. 
Figure 6- A higher magnification of the kidney in figure 5. The interstitial infiltrate is 
composed primarily of plasma cells, and lymphocytes. H&E stain. Bar = 40 /mi. 
Figure 7- Photomicrograph of a section of pancreas from a strain 82 inoculated dog (Dog 6) 
at 7 days PL The interlobular interstitium is infiltrated by moderate numbers of a mixed 
population of lymphocytes, plasma cells, neutrophils, and macrophages. H&E stain. Bar = 
40 fim. 
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Table 2-The major lesions present in kidney, liver, and pancreas are summarized for each day post-inoculation (PI). 
Group Day PI 
Controls 
7 
14 
22 
28 
Strain 82 
7 
9 
10 
11 
#11 
12 
#12 
Strain RM52 
7 
12 
13 
14 
22 
Kidney 
Interstitial Tubular Tubular 
Liver Pancreas 
Tubular Vasculitis Individualization Necrosis Interstitial 
nephritis Mineral degeneration dilation pancreatitis 
0/1 
0/1 
0/1 
0/2 
0/1 
0/1 
0/1 
0/2 
0/1 
0/1 
0/1 
0/2 
0/1 
0/1 
0/1 
0/2 
0/1 
0/1 
0/1 
0/2 
0/1 
0/1 
0/1 
0/2 
0/1 
0/1 
0/1 
0/2 
0/1 
0/1 
0/1 
0/2 
3/3+ 3/3- 1/3+ 3/3- 1/3++ 3/3- 1/3+ 1/3++ 
2/3- 2/3+ 2/3- 1/3+ 
1/3-
1/1++ 1/1- 1/1++ 1/1- 1/1+ 1/1+++ 1/1+ 1/1+ 
1/1+++ 1/1++ 1/1+++ 1/1- 1/1++ 1/1++ 1/1+ 1/1+ 
1/1+++ 1/1- 1/1+++ 1/1- 1/1+ 1/1+ 1/1+ 1/1-
1/1+++ 1/1+ ND ND 1/1+ 1/1++ 1/1+ 1/1+ 
1/4+++ 1/4++ 2/4++ 3/4++ 1/4++ 2/4+ 3/4+ 1/4+ 
3/4++ 1/4+ 2/4+ 1/4+ 3/4+ 2/4- 1/4- 2/4-
2/4- 1/4 ND 
1/1+++ 1/1+++ 1/1 ND 1/1 ND 1/1- 1/1++ 1/1++ 1/1-
3/3- 3/3- 3/3- 3/3- 3/3- 3/3- 3/3- 3/3-
2/2+++ 2/2- 1/2++ 1/2++ 1/2+++ 1/2++ 1/2++ 2/2-
1/2+ 1/2+ 1/2++ 1/2+ 1/2-
1/1+++ 1/1+ 1/1+ 1/1++ 1/1- 1/1- 1/1+ 1/1+ 
2/2- 2/2- 2/2- 2/2- 2/2- 2/2- 2/2- 2/2-
3/3- 1/3++ 3/3- 3/3- 2/3+ 3/3- 3/3- 3/3-
1/3- 1/3-
3/3- 3/3- 3/3- 3/3- 3/3- 3/3- 3/3- 3/3-
- = no change evident; + = mild; + + = moderate; + + + = severe 
ND = not examined; PI=post-inoculation; # these animals died (were not euthanized) 
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infiltrates of neutrophils, lymphocytes, and plasma cells at days 7-12 PI (Fig. 1) and 
individualization of hepatocytes and piecemeal hepatic necrosis with multifocal plugs of bile 
pigment within bile canaliculi at days 9-12 PI (Fig. 2). Increased numbers of mitoses were 
often noted when compared to control tissues (Fig. 3). Prominent lesions in the kidney were 
interstitial nephritis, mineralization, tubular dilation, and tubular degeneration (Fig. 4-6). 
Infiltrates of neutrophils between lobules of the pancreas were present in six dogs (Fig. 7). 
Immunoreactivity to serovar Grippotyphosa lipopolysaccharide was present in proximal 
convoluted tubular lumina and within interstitial vessels. The sites of immunoreactivity were 
small and multifocal with a granular to globular appearance. 
Clinical Pathology findings—Consistent clinical pathology alterations at necropsy in strain 
82 infected dogs were azotemia, hyperphosphatemia, increased anion gap, 
hyperbilirubinemia, and increased alkaline phosphatase (Table 3). When necropsy data for 
BUN, Creatinine, phosphorus, anion gap, TCOa, ALT, ALP, GGT, and total bilirubin were 
compared to baseline values by the paired T-test for strain 82 inoculated dogs, there was 
evidence for a significant difference at the p<0.001 level. CBC results associated with 
disease in strain 82 infected dogs included leukocytosis with mature neutrophilia (p<0.003). 
The two strain RM52 infected dogs, for which samples were available for analysis had 
similar complete blood count and serum biochemical abnormalities that included 
neutrophilia, marked hyperkalemia, relative hypercalcemia, hypoalbuminemia, 
hyperphosphatemia, elevated BUN and creatinine, markedly elevated ALP, 
hyperbilirubinemia, and elevated anion gap (data not shown). 
Serology—Three strain 82 inoculated dogs had titers at necropsy: two at 1:25 and 
one at 1:50. Three strain RM52 inoculated dogs had 1:25 titers at day 14, but agglutination 
Table 3-Clinical pathology data for strain 82 infected dogs is summarized. Baseline values are compared to necropsy results 
using the paired t-test. There is evidence for a significant difference between baseline and post-infection values at the p<0.001 for 
values that suggest renal (BUN, creatinine, phosphorus, anion gap, TCO2) and hepatic (ALT, ALP, GGT, total bilirubin) lesions. 
Elevations in baseline values for ALP and Phosphorus relative to the reference interval were considered normal for dogs of this 
age. 
Selected Parameters Baseline Reference Interval Post-Infection 
BUN mg/dl* 15 ± 5 10-30 220 ± 52 
Creatinine mg/dl* 0.3 ± 0.06 0.1 -1.2 4.6 ± 1.5 
Phosphorus mg/dl* 8.3 ± 0.7 3.2 - 6.2 21.9 ±5.8 
Anion Gap* 19.4 ± 1.5 11-20 37.1 ±7.5 
TCO2 mEq/L* 23.9 ± 1.7 17-24 14.9 ±2.8 
ALT IU/L* 25.0 ± 4.4 24 - 105 71.4 ± 18.4 
ALP IU/L* 173.0 ±76.8 20-115 1269.1 ±583.9 
GGT IU/L* 5.8 ±5.5 1 - 10 15.2 + 3.7 
Total Bilirubin mg/dl* 0.2 ± 0.1 0.1-0.6 4.8 ± 1.7 
WBC xlOV* 15.6+3.2 5.5-19.5 27.7±5.9 
Neutrophils xlO%il f 10.8+2.4 2.5-12.5 23.5±5.1 
* Values mean ± SD. significantly different * (p < 0.001) or ^(p<0.003) paired t test. 
was not noted in samples taken from two of these dogs at later time points. No other 
agglutinating antibody titers of 1:25 or greater were noted in strain RM 52 inoculated dogs. 
DISCUSSION 
In this study, two different isolates of Leptospira kirschneri serovar Grippotyphosa 
were used to inoculate young, seronegative dogs. One isolate (strain RM 52) was derived 
from swine tissues whereas the other (strain 82) was isolated from the urine of a dog with a 
clinical leptospirosis. Clinical signs, onset of disease, and gross and microscopic lesions 
were similar between dogs infected with the two different isolates of serovar Grippotyphosa, 
but fewer dogs were infected after inoculation with the swine derived isolate, strain RM 52, 
(3/14) than after inoculation with the canine-derived isolate, strain 82 (12/12). Hamster 
passage was used to restore virulence prior to inoculation of dogs, but adaptation of strain 
RM 52 to culture conditions after multiple passages may have resulted in the loss of factors 
related to virulence22 in dogs. Alternatively, the swine derived strain may not be as virulent 
for dogs. Cultured leptospires have been shown to express different proteins than host-
derived leptospires.10 Change in the expression patterns of proteins associated with bacterial 
entry of strain RM 52 after repeated culture is one explanation for the fewer dogs infected 
after inoculation with this organism. Strain 82 organisms were passed in culture only once 
since isolation from the original dog in 1992 , which may have allowed retention of the 
characteristics that allowed it to infect the original host. 
Clinical signs of canine leptospirosis are often nonspecific and may include fever, 
myalgia, anorexia, vomiting, and diarrhea, 23,24 and signs may vary depending on the infecting 
serovar. At seven days post-inoculation, signs were mild and limited to lethargy and mild 
scleral hyperemia. Dogs that became infected developed severe clinical signs as early as 9 
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days PI with clinical illness worsening and resulting in death or euthanasia up to day 13 PL 
Other signs in acutely ill dogs in the 9 to 13 day post-inoculation period included lethargy, 
vomiting, and anorexia. Fevers were only detected in three strain 82 inoculated dogs. A 
greater incidence was expected since fever is commonly listed as a clinical sign of 
leptospirosis. As body temperature data were only collected twice daily, it is possible that a 
transient febrile period was missed in some dogs. 
A previous study established that acute renal failure can occur in dogs as a result of 
infection with serovar Grippotyphosa, but suggested hepatic disease was a minor 
component.5 In our study, serum biochemical profiles and histologic lesions of acutely ill 
dogs were indicative of severe renal and hepatic disease. At 7 days PI, lesions were present in 
kidney and liver. There were small multifocal lymphoplasmacytic interstitial infiltrates in the 
kidney and perivascular infiltrates of lymphocytes, plasma cells, and fewer neutrophils in the 
liver. Histologic lesions in acutely ill dogs on days 9-13 PI were more severe, with renal 
lesions consisting of more extensive lymphoplasmacytic interstitial nephritis, tubular dilation 
with flattened epithelium (a sign of tubular repair after epithelial cell loss), and multifocal 
tubular mineralization. Immunoreactivity to serovar Grippotyphosa lipopolysaccharide was 
demonstrated in small quantities in renal tubular lumina and interstitial vessels. Staining was 
less intense than in dogs described previously.19 The amount of immunoreactivity may be 
related to duration of infection, but the duration of infection in the previous study in which 
this antibody was applied to canine tissue was not known. In the liver, hepatocytes had lost 
glycogen stores, contained numerous small clear vacuoles (lipid), and were individualized and 
dissociated from hepatic laminae. Multifocal bile plugs were present, and lymphocytes and 
neutrophils were increased around hepatic portal veins and diffusely throughout the sinusoids. 
One dog had an intussusception at necropsy, a finding that has been previously described in 
leptospirosis.20,24,25 Elevated biochemical parameters in non-recovering dogs indicated renal 
and hepatic damage and acid-base abnormalities. There were significant elevations in BUN, 
creatinine, and phosphorus in blood drawn at the time of necropsy compared to baseline values 
indicating that greater than 75% of the renal parenchyma was affected. Elevated ALT 
indicates leakage of hepatocytes, and markedly elevated ALP, GGT, and bilirubin indicate 
cholestasis. Bile flow was most likely disrupted by the dissociation of hepatocytes from 
hepatic laminae and swelling of hepatocytes due to lipid accumulation. Elevated anion gap and 
decreased TCO 2 indicated metabolic acidosis, likely titrational with loss of bicarbonate due 
to overabundance of uremic acids. Two acutely ill strain RM 52 dogs were markedly 
hyperkalemia due to potassium redistribution and failure of renal potassium excretion 
(anuria/oliguria). Redistribution occurs in acidosis when H+ moves intracellularly and K+ 
becomes extracellular resulting in increased extracellular K+ levels.26 
Dogs inoculated with strain RM 52 and necropsied on days 14,22, or 28 PI did not 
have lesions except for two dogs with mild perivascular hepatic infiltrates. These dogs did not 
have evidence of infection by culture, immunofluorescence, or serologic testing. It is possible 
that organisms never entered the vasculature at the mucous membrane surface, or organisms 
entered the bloodstream, but were cleared before attempts were made to culture the blood. 
Previous experiments show that leptospires can be rapidly phagocytosed by tissue 
macrophages after inoculation.27 Since control dogs did not have lesions similar to the 
inoculated dogs, these mild lesions in kidney and liver may have been the result of tissue 
damage due to leptospires present transiently in those tissues prior to phagocytosis. 
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Serologic tests for leptospirosis in dogs include the MAT9 and enzyme-linked 
immunosorbent assay.28 The MAT is commonly used as a diagnostic test in clinical situations, 
so serum samples of all inoculated dogs were analyzed, if available. However, the results of 
serologic tests can be confounded by several factors. Serology is complicated by antibody 
cross-reactivity between different serovars and the presence of low-titers during acute 
disease.3,5'7 Previously vaccinated dogs may have elevated titers that further complicate 
diagnosis, and some dogs may become infected and actively shed organisms without ever 
having a titer greater than 1:10029 while others become seronegative after appropriate 
treatment.30 No serologic titers greater than 1:50 were obtained from any dog inoculated with 
either strain of serovar Grippotyphosa in this experiment. The most likely explanation for 
this result is the short time period between inoculation and the onset of clinical illness. 
To better understand the course of clinical disease and biochemical abnormalities in 
dogs infected with leptospirosis, 26 dogs were inoculated with Leptospira kirschneri serovar 
Grippotyphosa. To the authors' knowledge, this is the first complete, published study to 
report results of experimental mucous membrane inoculation with serovar Grippotyphosa. 
Two strains of serovar Grippotyphosa were used: strain RM 52 a swine derived isolate and 
strain 82 a canine isolate. Biochemical changes, gross and histopathologic lesions, and 
positive culture and immunofluorescence results occurred in a greater number of dogs 
inoculated with the canine isolate. However, the character of gross, histologic, and 
biochemical lesions were similar in time course and severity in dogs infected by either strain. 
Lesions and clinical pathology results suggest that infection with serovar Grippotyphosa 
results in severe renal and hepatic damage. The reason for the different rate of infection 
between these two different strains of serovar Grippotyphosa is not clear, but may be due to 
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changes that occurred in the original host (canine vs. swine), altered bacterial protein 
expression from culture passage, or differences in isolates from different geographical areas. 
Because of the efficient rate of infection and consistent production of hepatic and renal 
lesions strain 82 would make a good candidate for use in further study of treatment and 
preventative measures for acute canine leptospirosis. 
a Lasix, Patheon Pharmaceuticals Inc., Cincinnati, OH 45215 USA 
b Beuthanasia®-D Special, Schering-Plough Animal Health, Inc., Kenilworth, NJ 07033 
c Sigma-Aldrich Corp., St. Louis, MO 
d PLM 5, Intergen Co., Purchase, NY 
e Becton, Dickinson and Company, Franklin Lakes, NJ 
f BSA; Sigma, St. Louis, MO 
g Fisher Chemicals, Fairlawn, NJ 07410 
h NBS, donkey; Vector Laboratories Inc., Burlingame, CA94010 
1 Vector Elite ABC Kit; 1:600; Vector, Burlingame, CA 94010 
j NOVA RED, Vector Laboratories, Burlingame, CA 94010 
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ABSTRACT 
Objective— To determine the pattern of gross and histopathologic lesions and biochemical 
alterations caused by Leptospira interrogans serovars Pomona and Bratislava. 
Animals—27 eight-week-old, female beagle dogs. 
Procedure—Beagles were randomly assigned to challenge or control groups. Challenge 
groups were inoculated on three successive days by conjunctival instillation of 5x1 (f cells of 
either L. interrogans serovar Pomona (n=12) or serovar Bratislava (n=l 1); control dogs (n=4) 
were inoculated with sterile leptospiral culture media. Clinical signs were recorded and 
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clinical pathology assays and necropsies (7/timepoint) were done at 7, 10,14, and 20 days 
post-inoculation (PI). 
Results— Infection could not be confirmed in any serovar Bratislava inoculated dog, and 
control dogs remained healthy throughout the experiment. Positive culture and fluorescent 
antibody test results were confirmed in 92% (11/12) of serovar Pomona inoculated dogs. 
Fever and lethargy starting at day 7 PI were the most common clinical signs in serovar 
Pomona infected dogs. On day 10, gross lesions included multifocal renal and pulmonary 
hemorrhage and perirenal edema. Serovar Pomona inoculated dogs had histologic lesions 
including portal hepatitis, interstitial nephritis, and pneumonia at 7, 10, 14, and 20 days PL 
Elevations in BUN, anion gap, and bilirubin occurred on days 10, 14, and 20 PL Platelet 
counts from culture positive dogs were decreased from baseline values on days 10, 12, and 
14 PI. 
Conclusions and Clinical Relevance—Conjunctival inoculation with L. interrogans serovar 
Pomona, but not serovar Bratislava resulted in a high rate of infection with concomitant 
hemorrhagic and inflammatory lesions of the kidneys, liver, and lungs. 
INTRODUCTION 
Leptospirosis, one of the most widespread zoonotic diseases,1 is a reemerging cause 
of renal failure and hepatic disease in dogs.2 The diagnosis of canine leptospirosis in the 
United States and Canada significantly increased between 1983 and 1998.3 Traditionally, 
Leptospira interrogans serovars Canicola and Icterohemorrhagiae have been a major cause 
of canine leptospirosis. Experimental disease caused by serovars Canicola and 
Icterohemorrhagiae has been described,4"11 and the use of vaccines containing these serovars 
has markedly reduced the incidence of disease caused by them.12'13 However, in the last 
decade, other serovars such as L. kirschneri serovar Grippotyphosa and L. interrogans 
serovars Pomona and Bratislava have been associated with an increasing percentage of 
reported cases,2'3'12'14-16 and until recently, vaccines have not been available to protect 
against them. Features of canine leptospirosis that may be serovar specific have not been 
well characterized because of the paucity of experimental studies and the inability to 
determine the time of exposure in clinical cases. Experimental studies are needed to better 
understand the progression of clinical signs and clinicopathologic abnormalities in the course 
of disease with these re-emerging serovars. The purpose of this experiment was to inoculate 
dogs with L. interrogans serovars Pomona and Bratislava and document clinical signs, 
changes in CBC and biochemistry profiles, and gross and histologic lesions at necropsy. 
MATERIALS AND METHODS 
Dogs—Twenty-seven 8-week-old female beagle dogs without detectable antibodies 
to L. interrogans serovars Bratislava or Pomona by Microscopic Agglutination Test (MAT)17 
were obtained from a commercial laboratory animal vendor.3 Upon arrival dogs were 
examined for uniformity and randomly divided into three groups: 4 control dogs, 12 serovar 
Pomona inoculated dogs, and 11 serovar Bratislava inoculated dogs. Inoculated dogs were 
housed in BL-2 rooms at Iowa State University. Dogs were housed in pairs in a room 
maintained at a constant temperature and humidity. Cages were cleaned once daily and food 
and water were available at all times and freshened twice daily. All animal experiments 
were performed with the approval of the Iowa State University Committee on Animal Care. 
Leptospira preparation— Two different bacterial isolates were used. L. interrogans 
serovar Pomona type kennewicki strain RM211 was isolated at the USDA/ARS-National 
Animal Disease Center from neonatal kidney and liver tissues from an Iowa swine herd that 
were submitted to the Veterinary Diagnostic Laboratory at Iowa State University.18 The herd 
had a history of 25 of 75 pregnancies resulting in abortion or stillbirth. L. interrogans 
serovar Bratislava strain Alex was isolated from urine obtained from a dog in Indiana with a 
1:640 titer to serovar Bratislava by microscopic agglutination test (MAT).19 
Experimental design— Inoculations occurred after a 6 day acclimation period. Two 
days prior to inoculation, samples were taken from each dog for complete blood count, serum 
biochemistry profile, and urinalysis, and no abnormalities were noted. The dogs were 
observed for clinical signs at least twice daily and temperatures recorded once daily 
throughout the experiment. Dogs were challenged on three consecutive days (Day 0, 1, and 
2) with 5xl07 leptospires in 250 /xl of 80/40 liquid culture media20 per eye ( a concentration 
of 2xl08 per ml), which was placed onto the corneal surface of each eye of each dog and 
allowed to run onto the conjunctiva. Dogs 1-4 (N=4) served as controls and were 
inoculated with an equal volume of sterile culture media. Dogs 5-16 (N=12) were inoculated 
with L. interrogans serovar Pomona type kennewicki strain RM 211. Dogs 17-27 (N=12) 
were inoculated with L. interrogans serovar Bratislava strain Alex. 
Necropsy and Sample collection—On days 5, 8, and 12 of the experiment and at 
necropsy, blood was drawn for blood culture. Prior to necropsies done on days 7, 10,14, and 
20 additional blood samples were drawn from all dogs for CBC and serum biochemistry 
panels including sodium, potassium, chloride, total CO2 (TCO2), calcium, phosphorus, blood 
urea nitrogen, creatinine, glucose, total protein, albumin, alanine aminotransferase (ALT), 
alkaline phosphatase (ALP), y-glutamyltransferase (GGT), creatine kinase (CK), direct 
bilirubin (Dbili), total bilirubin (Tbili), and anion gap. For each time point, 3 dogs 
inoculated with each serovar and one control dog were necropsied. During necropsy, liver, 
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kidney, and urine were taken aseptically for culture and immunofluorescence testing. 
Samples of kidney, liver, lung, hepatic lymph node, adrenal gland, spleen, heart, tonsil, 
mesenteric lymph node, pancreas, stomach, jejunum, vulva, bladder, bone marrow, iliac 
lymph node, colon, ileum, and cecum were collected into 10% neutral buffered formalin. An 
eye and conjunctival sample were collected into Bouin's solution. 
Histopathology—Tissues for histologic evaluation were collected into 10% neutral 
buffered formalin and processed by standard paraffin embedding techniques after 24 hours. 
Sections were cut at 5 |am except for kidney, lymph nodes, and adrenal gland, which were cut 
at 3 (am. All sections were stained with hematoxylin and eosin. Histopathologic grading of 
selected lesions of liver, kidney, and pancreas was done using no change (-), mild (+), 
moderate (++), and severe (+++) designations. For interstitial nephritis, tubular 
mineralization, and hepatic vasculitis the scores were assigned as follows: (-) = no change 
from control dogs, (+) =1-3 foci/section examined, (++) =4-6 foci/section examined, (+++) = 
(>6 foci/section examined). Tubular degeneration was graded (+) when scattered cells were 
noted with pyknotic nuclei or loss of polarity, (++) when these changes were present in larger 
sections of a tubule, and (+++) when multiple tubules in an area were affected. Tubular 
dilation was scored (+) when scattered tubular lumens were markedly widened and lined by a 
thin layer of epithelium, (++) when multiple tubules were affected, and (+++) when the 
cortex was diffusely affected. Pancreatitis was (+) when small numbers of inflammatory 
cells were present between lobules, (++) when there was infiltration of the lobules by 
inflammatory cells, and (+++) for diffuse inflammation throughout the pancreas. 
Bacteriologic culturing and Polymerase Chain Reaction—Blood cultures were 
performed on post-inoculation days 5, 8, 10, 12, 14, and 20. Liver and kidney samples of 
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approximately 1 gram and aqueous humor and urine samples of 1 ml were obtained at 
necropsy and processed for isolation of leptospires. Three media were used for isolations. 
First, Tween 80/Tween 40/lactalbumin hydrolysate was used as previously described20 with 
slight modifications: 5-fluorouracil was used at a rate of lOOpg/ml, and naladixic acid was 
not used. Second, Ellinghausen-McCullough-Johnson-Harris (EMJH) semisolid media was 
used as previously described21 with the modifications of 10% BSA, 100 p.g/ml 5-fluorouracil, 
and 1% rabbit serum. Finally, commercial Polysorbate Leptospira Medium 5b was used with 
the addition of purified agar and 100p,g/ml 5-fluorouracil. Cultures were incubated at 29° C 
for 6 months. Darkfield exam was performed at 1, 2,4, 6, and 8 weeks and at 3, 4, 5, and 6 
months. If cultures became contaminated, approximately 1 ml was filtered through a 0.22 
|am filter into new medium. Representative isolates were identified by restriction 
endonuclease analysis of chromosomal DNA.22 Isolation of genomic DNA was done using 
a commercial kitc and amplification by PCR was performed on kidney as previously 
described.23 
Serologic examination—Blood was obtained from dogs prior to inoculation and at 
days 7,10,14, and 20 post-inoculation. Serum was separated and tested for the presence of 
agglutinating antibodies against serovars Pomona or serovar Bratislava, respectively, using 
the microscopic agglutination test.17 
Immunofluorescence test—Samples of urine, kidney, aqueous humor, and liver 
were stained with equal amounts of fluorescein-labeled rabbit anti-serovar conjugate as 
previously described.24 Leptospires were identified by typical size, morphology, and 
fluorescence when examined by incident light fluorescence microscopy. 
Immunohistochemistry— Immunohistochemical staining was done on a subset of 
animals to determine the patterns of antigen distribution after infection was confirmed by 
positive culture or immunofluorescence. Two primary antisera were used at the stated 
dilutions: polyclonal rabbit antisera specific to the outer membrane protein OmpLl,25 #338 
(1:6,000); and polyclonal rabbit antisera with serovar Pomona specificity (1:8,000) as 
previously described.26 Briefly, 5 jam sections were cut, placed on positively charged slides, 
and deparafinized with xylene and ethanol by standard procedures. Slide mounted tissue 
sections were rinsed in potassium phosphate buffered solution (KPBS; 0.15 M NaCl, 0.034 
M K2HPO4, 0.017 M KH2PO4, pH 7.4), and antigen retrieval was performed by incubating 
slides for 7 minutes in 37 C KPBS with 0.1% trypsin and 0.1% CaC^. After 2 rinses in 
KPBS, endogenous peroxidase activity was eliminated by 30 minute incubation in 0.3% 
hydrogen peroxide solution in KPBS. The sections were then incubated for two hours in 
blocking solution (KPBS with 1% bovine serum albumin,d 0.4% Triton X-100,e and 1.5% 
normal blocking serum/ and incubated overnight at room temperature (24°C) in primary 
antiserum. On the following day, tissue sections were rinsed in KPBS with 0.2% Triton X-
100 and incubated in an appropriate biotinylated secondary antibody for two hours at room 
temperature, rinsed, and incubated in Horseradish Peroxidase-Avidin-Biotin Complex8 for 1 
hour at room temperature. Enzyme reactions were developed with a substrate kit producing a 
red reaction.11 The reaction was terminated in successive rinses of 0.9% NaCl solution. 
Slides were counterstained with hematoxylin, dehydrated through graded alcohols, and 
Clinical signs and microbiology— Clinical signs in serovar Pomona inoculated dogs 
began 7 days PI and included lethargy, fever, and inappetence. Seven serovar Pomona 
inoculated dogs were febrile (range 39.3 C to 40.2) on days 7 (1/7), 8-9 (2/7), 11-13 (3/7), 
and 17-18 (1/7). Three serovar Pomona inoculated dogs had loose feces with small amounts 
of blood on days 7 to 10 PL One dog necropsied on day 20 presented with a wasting 
syndrome characterized by poor food intake, rough hair coat, scant, dark feces, and weight 
loss. Clinical signs were not detected in control or serovar Bratislava inoculated dogs. 
A dog was considered infected if leptospires were detected in tissues or body fluids 
by culture, immunofluorescence, or immunohistochemistry. Culture and 
immunofluorescence test results (Table 1) were negative in all control dogs (5/5; 100%). 
Serovar Bratislava was not detected in any tissue by bacterial culture or immunofluorescence 
testing. Serovar Pomona was detected 11 of 12 (92%) inoculated dogs. Blood culture of 
Pomona inoculated dogs (11/12) was positive at 7 or 8 days PI, but infection could not be 
confirmed by any other method at those early times. Culture, immunofluorescence testing, 
and PCR methods were positive in these dogs (8/9) after day 10 PI. Leptospires were 
cultured from kidney (8/9), urine (5/7), aqueous humor (5/9), and liver (6/9) at day 10 PI or 
later, and 11 of 12 dogs were positive by PCR during that time period. Immunofluorescence 
testing demonstrated leptospiral antigen in kidney (8/9), liver (6/9), and urine (5/7) at 
necropsy when performed at day 10 PI or later. 
Necropsy—No abnormalities, except ocular discharge and conjunctival hyperemia in 
2 serovar Pomona inoculated dogs at day 10 PI were noted upon external examination prior 
to necropsy. One serovar Pomona inoculated dog necropsied at day 10 PI continued to bleed 
Table 1- Summarized results of bacterial culture and immunofluorescence (FA) testing expressed as number of positive results 
obtained/number of animals tested per group. 
Culture Immunofluorescence Test 
Blood Blood Blood Blood* Kidney Liver Urine Aq. Humor Kidney Liver Urine 
5 PED 8 PID 12 PID 
Control 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 ND 
serovar Pomona 0/12 8/9 5/6 6/8 8/12 6/12 5/10 5/12 8/12 6/12 5/7 
serovar Bratislava 0/11 0/9 0/6 0/11 0/11 0/11 0/11 0/11 0/11 0/11 0/10 
*necropsy sample 
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for an abnormally long period of time after venipuncture. Gross lesions were evident in 
serovar Pomona inoculated dogs necropsied on days 10,14, and 20 and consisted of 
multifocal pulmonary (Fig. 1) and renal hemorrhage (Fig. 2-3), perirenal edema, friable liver 
with multifocal 1-2 mm raised white foci, and enlarged and reddened hepatic and internal 
iliac lymph nodes. One serovar Pomona inoculated dog (see wasting syndrome above), 
which had been febrile on days 11 and 13 and necropsied at day 20 had dark, bloody feces; a 
friable, pale, and yellow liver; and multiple brown ecchymotic pulmonary hemorrhages. No 
gross lesions were present in serovar Bratislava inoculated dogs. 
Histopathology and Immunohistochemistry—Tissues from 7,10,14, and 20 day 
necropsies of serovar Pomona inoculated dogs had histologic lesions in liver, kidney, and 
lungs. Lesions at day 7 were subtle and confined to perivascular inflammation in the liver 
and multifocal interstitial nephritis. A single serovar Pomona dog had a focus of coagulative 
hepatic necrosis. On day 10, there was pulmonary (Fig. 4) and renal hemorrhage (Fig. 5), 
coalescing interstitial nephritis, and heavier infiltrates of lymphocytes, plasma cells, and 
neutrophils in portal areas and around hepatic portal veins. On day 14 and 20, multifocal 
renal hemorrhage was present, interstitial nephritis was more intense (Fig. 6), and hyaline 
droplets (Fig. 7) were prominent in the tubular epithelium. Periportal inflammatory 
infiltrates of lymphocytes, plasma cells, neutrophils, and macrophages were denser, there 
were a few small foci of hepatic necrosis, and multifocal bile plugs within bile canaliculi. 
Dilated proximal convoluted tubules with flattened epithelium and mineral deposits were 
present at day 20 PI only. Lesions that occurred less frequently in infected dogs were renal 
tubular syncytia, endocarditis and epicarditis, and focal pneumonia. In the heart, there were 
infiltrates of neutrophils, lymphocytes, and fewer plasma cells around multiple veins and 
FIGURE LEGENDS 
Figure 1- Right lung from a Leptospira interrogans serovar Pomona strain RM 211 
inoculated dog at 10 days PL There are multifocal petechial hemorrhages that occasionally 
coalesce. 
Figure 2- Kidney form a serovar Pomona inoculated dog at 10 days PI. There are multifocal 
subcapsular hemorrhages. 
Figure 3- Kidney from a serovar Pomona inoculated dog at 10 days PI. Multifocal 
irregularly shaped hemorrhages extend from the cortical surface to the cortico-medullary 
junction. 

FIGURE LEGENDS 
Figure 4- Photomicrograph of a section of lung from a serovar Pomona inoculated dog at 10 
days PL Multiple alveoli are filled with free erythrocytes. H&E stain. Bar=50 fim. 
Figure 5- Photomicrograph of a section of kidney from a serovar Pomona inoculated dog at 
10 days PL The interstitium is expanded by edema fluid, free erythrocytes, and infiltrates of 
lymphocytes, plasma cells, and neutrophils. H&E stain. Bar=50 jum. 
Figure 6- Photomicrograph of a section of kidney from a serovar Pomona inoculated dog at 
20 days PL Interstitial infiltrates are composed primarily of plasma cells, and lymphocytes. 
H&E stain. Bar=50 fim. 
Figure 7- Photomicrograph of a section of kidney from a serovar Pomona inoculated dog at 
20 days PL Hyaline droplets are abundant in proximal convoluted tubular epithelial cells. 
H&E stain. Bar=20 fim. 
Figure 8- Immunohistochemical staining of a section of kidney from a serovar Pomona 
inoculated dog at 20 days PL There is immunoreactivity with polyclonal 338 (antisera to 
OmpLl) within multifocal proximal tubules, but not within foci of interstitial inflammation. 
Bar=50 /tin 
Figure 9- A higher magnification of the immunohistochemical staining in figure 8. Intense 
immunoreactivity to leptospiral antigens is associated with organisms attached to the 
microvillous surface of the proximal convoluted tubule. Bar=20 fim 
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Table 2- The major histologie lesions present in kidney and liver are summarized for each day post inoculation (PI). 
Group Kidney Liver 
Interstitial Tubular Tubular degeneration Hepatitis Bile plugs 
nephritis Mineral and dilation 
Serovar Pomona 
Day PI 
7 3/3 + 2/3 + 
10 1/3 + 
2/3 +++ 2/3 + 
14 3/3 +++ 1/3+ 
1/3++ 
20 1/3+4- 2/3+ 
1/3+++ 
lack of lesions (-) not listed unless all animals were negative 
1/3+ 1/3+ 3/3 -
1/3++ 
2/3+ 2/3+ 3/3-
1/3+++ 
1/3 ++ 1/3+ 1/3 
1/3 +++ 1/3 + 1/3 ++ 
1/3 +++ 1/3 + 1/3 +++ 
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arteries, subjacent the endocardium, and within the epicardium and epicardial fat. In the 
lungs, groups of alveoli were filled and alveolar septa expanded with erythrocytes, serum, 
fibrin, degenerate neutrophils, and fewer lymphocytes and macrophages. In sections of 
perirenal fat examined from dogs with perirenal edema, there was necrosis of fat and heavy 
infiltrates of lymphocytes, plasma cells, neutrophils, and macrophages. Sections examined 
from the enlarged, reddened lymph nodes contained large numbers of free erythrocytes 
within the medulla. Erythrocytes often formed rosettes around or were within macrophages. 
There was immunoreactivity to polyclonal antisera 338 at the brush border of 
multifocal proximal convoluted tubules (Fig. 8) and at the luminal surface of bile duct 
epithelium. The pattern of immunoreactivity was consistent with intact leptospires (Fig. 9). 
There was a similar pattern of immunoreactivity with the anti-pomona antisera. No intense 
immunoreactivity was noted in inflammatory infiltrates of kidney, liver, or lung. 
Clinical Pathology findings—Sporadic elevations in blood urea nitrogen (BUN), anion gap, 
and bilirubin were present only in serovar Pomona infected dogs. BUN levels were elevated 
in two dogs on day 10 PI and a single dog on each of days 14 and 20 PL There were not 
concomitant elevations in creatinine. Elevation in Dbili, Tbili, GGT and ALP were noted in 
4 dogs on day 14 PI and a single remaining dog (from this group of 4) that was necropsied on 
day 20 PI. Elevations in ALP ranged from 834IU/L to 1413 IU/L (reference interval 20-115 
IU/L). Platelets from culture positive dogs were decreased from baseline values on days 9, 
11, and 13 PI (Fig. 8). A single dog infected with serovar Pomona had a slightly prolonged 
PTT on day 10 PI (21.1 sec; reference interval 8.9-18.7 sec). On day 14 PI, 2 serovar 
Pomona inoculated dogs had glucose (+) and bilirubin (3+) in the urine. Results from CBC 
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and serum biochemistry profiles in serovar Bratislava inoculated dogs did not differ from 
control dogs. 
Serology—MAT titers of 1:100 were detected in two serovar Bratislava inoculated 
dogs at day 20 PL. Two serovar Pomona inoculated dogs had MAT titers of 1:200 and 
1:800, respectively, at 20 days PL The dog with a 1:800 titer to serovar Pomona at day 20 PI 
also had a 1:200 titer at day 14 PI, but no other agglutinating antibody titers of 1:25 or 
greater were noted in any dogs. 
Figure 8-There was a transient decrease in platelet numbers in clinically ill dogs at days 9-13 
post-inoculation when compared to control dogs. Average platelet counts for infected dogs 
are expressed as a percent of pooled control samples. 
200 —, 
i 4 6 9 II 13 19 
Days Post Innoculatlon 
DISCUSSION 
A canine model was used to study leptospiral infection by L. interrogans serovars 
Pomona and Bratislava. Leptospiral infection was confirmed in all except one serovar 
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Pomona inoculated dog by positive culture and immunofluorescence tests. Serovar Pomona 
infected dogs had clinical signs including lethargy, loose feces with flecks of blood, and 
fever. At days 10,14, and 20 PI, there was gross and microscopic evidence of hemorrhage of 
kidney and lung in serovar Pomona inoculated dogs that was associated with a mild transient 
decrease in platelet numbers. There was no evidence of infection in any dogs inoculated with 
this canine-derived serovar Bratislava isolate. Dogs infected with serovar Pomona had 
unique clinical signs, clinicopathologic abnormalities, and lesion patterns when compared to 
infection with Leptospira kirschneri serovar Grippotyphosa.26 Serovar Grippotyphosa 
infection manifested as severe renal and hepatic failure resulting in severe biochemical 
abnormalities and death by 12 days PL Serovar Pomona infected dogs frequently had 
evidence of hemorrhage in lung and kidney, but fewer biochemical abnormalities, even 
though histologic lesions in kidney were more severe than those in serovar Grippotyphosa 
infected dogs. 
The presence of hemorrhage was supported by gross, histopathologic, and clinical 
pathologic data. Hemorrhage in serovar Pomona infected dogs was associated with sporadic 
increases in BUN, but were not accompanied by elevations in creatinine that can indicate 
gastrointestinal hemorrhage with absorption of blood. One of the dogs with elevated BUN 
had loose feces with flecks of blood prior to necropsy at day 10. A second dog with elevated 
BUN had large amounts of digested blood within the intestine at necropsy. 
Renal lesions were present in all serovar Pomona infected dogs. Interstitial nephritis 
increased in severity over the time course of disease, but was not associated with indicators 
of renal failure as in the case of inoculation of dogs with Leptospira kirschneri serovar 
Grippotyphosa.26 Since most infected dogs had BUN and creatinine within the reference 
intervals, this indicates that greater than 25% of renal function remained, but does not 
exclude the possibility of renal disease. Hyaline droplets in the proximal convoluted tubules, 
formed when resorption by the cell outpaces the digestion of protein during pinocytotic 
vesicle fusion with lysosomes, suggest plasma protein leakage from abnormal glomerular 
capillaries or abnormal protein processing by tubular epithelium. Glucosuria without 
hyperglycemia, which occurred in 2 dogs at day 14 PI, further suggests a renal tubular 
dysfunction. 
Clinical pathology data and histopathologic examination in severely affected dogs 
suggested cholestasis on days 14 and 20 PI. Elevated total and direct bilirubin and markedly 
elevated ALP were noted in 4 dogs. These abnormalities were associated with histologic 
evidence of dense perivascular infiltrates of lymphocytes, plasma cells, macrophages, and 
neutrophils in portal areas, bile plugs in bile canaliculi, and multifocal areas of hepatic 
necrosis that corresponded to the multifocal raised white areas noted grossly. 
Several diagnostic methods were utilized to confirm leptospiral infection, and 
infection was confirmed in 11/12 serovar Pomona inoculated dogs. Blood culture was the 
most sensitive method of detecting infection by serovar Pomona at days 7 or 8 PI. PCR 
samples collected at the day 7 PI necropsies were negative, but PCR was attempted on renal 
tissue only. Only one dog had a MAT titer that would be diagnostic for leptospirosis by 
published standards of 1:800 to 1:3200 used in retrospective studies as evidence of 
leptospiral infection. 14'15 At 20 days PI, one serovar Pomona inoculated dog had a MAT 
titer of 1:200 and another had a titer of 1:800. 
Serovar Bratislava infection was not detected in any dog by immunofluorescence 
testing, culture, immunohistochemistry, or PCR. The inability of this canine derived isolate 
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to infect or cause disease in dogs may be a result of change in expression of virulence factors 
due to passage in culture. The organisms grew rapidly in culture indicating adaptation to 
culture conditions that often is associated with loss of virulence.27 Later, this isolate was 
used to challenge hamsters since they are highly susceptible to most pathogenic isolates of 
Leptospira, but there were no clinical signs (Alt, 2001 unpublished data). Infection with 
serovar Bratislava has been demonstrated in dogs in Great Britain with reproductive failure 
or renal disease.28, 29 
a Marshall Farms, North Rose, NY 
b PLM 5, Intergen Co., Purchase, NY 
c DNeasy tissue kit, Qiagen, Valencia, CA 
d BSA; Sigma, St. Louis, MO 
e Fisher Chemicals, Fairlawn, NJ 
fNBS, donkey; Vector Laboratories Inc., Burlingame, CA 
8 Vector Elite ABC Kit; 1:600; Vector Laboratories Inc., Burlingame, CA 
h NOVA RED, Vector Laboratories, Burlingame, CA 
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CHAPTER 4. LEPTOSPIRA INTERROGANS SEROVAR POMONA 
INFECTION IN GUINEA PIGS AND IN VITRO EVIDENCE OF 
LEPTOSPIRE BINDING OF PLATELETS 
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ABSTRACT 
Guinea pig inoculations and in vitro platelet binding assays were done to examine the 
pathogenesis of hemorrhage in leptospirosis. Thirty juvenile guinea pigs were inoculated 
intraperitoneally with Leptospira interrogans serovar Pomona type kennewicki (n=20) or an 
equal volume of sterile culture media (n=10). Guinea pigs were sequentially necropsied on 
days 2-6 post-inoculation (PI). CBC's, biochemistry profiles, and clotting assays 
(prothrombin time, partial thrombplastin time, D-dimers) were done during the course of 
disease and correlated with gross and histologic lesions. Tissue samples were taken for 
culture, immunofluorescence tests, and immunohistochemical staining to confirm infection. 
The infected guinea pigs had gross and histologic lesions beginning at 3 days PI. On days 3-
6 PI, the infected guinea pigs had decreased platelet counts relative to controls, multifocal 
hepatic necrosis, and hemorrhage in lung, kidney, liver, and heart. Microtiter assays and 
fluorescent microscopy were done to determine if leptospires bind guinea pig platelets. 
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Leptospires bound platelet monolayers, but not empty wells or control wells containing 
fibrinogen or platelet poor plasma. Binding was not inhibited by anti CD41 antibody or 5 
mM EDTA suggesting binding is not integrin mediated. Leptospires retained the ability to 
bind platelet monolayers after incubation in gelatin or dextran sulfate, which block 
fibronectin and glycosaminoglycan binding, respectively. 
INTRODUCTION 
Hemorrhage occurs in cases of leptospirosis in human beings1'2 and dogs,3 especially in the 
lungs and kidneys. The cause of this hemorrhage is not known, but hypotheses include 
physical damage to small vessels by leptospires, disseminated intravascular coagulopathy,4 
and the action of leptospiral toxins on the endothelium.5 Hemorrhage has been associated 
with thrombocytopenia,1 but specific interactions between leptospires and platelets have not 
been investigated. 
For other spirochetes, namely Borrelia burgdorferi and Borrelia hermsii, direct 
interactions between platelets and spirochetes have been demonstrated. Borrelia burgdorferi 
has been shown to bind activated platelets in an integrin allb/B (glycoprotein lib Ilia) 
dependent manner,6'7 and through an alternate cell surface proteoglycan mediated pathway.8 
Platelet binding plays a role in the thrombocytopenia associated with relapsing fever caused 
by Borrelia hermsii since the bacterium is able to activate platelets and promote further 
binding.9 
Guinea pigs are a commonly used model for leptospirosis studies, and previous 
studies have demonstrated hemorrhage in experimental cases.10'11 Leptospira interrogans 
serovar Pomona has not been thoroughly investigated in a guinea pig model, nor have direct 
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interactions between leptospires and platelets been described. While a decrease in platelet 
number is a common feature of leptospirosis, the correlation between platelet number, 
platelet function, and onset of clinical signs post-inoculation remains ill defined.5'12 
The mechanism of hemorrhage in leptospirosis is unknown and the affect of 
leptospires on platelets requires study. These experiments were designed to determine if 
hemorrhage occurs in a guinea pig model of serovar Pomona infection, and to test the 
hypothesis that leptospires interact directly with blood platelets in vitro. Experiment one was 
performed to determine if hemorrhage is a consequence of serovar Pomona infection in 
guinea pigs as it is in dogs. The objective of experiment two was to obtain guinea pig 
platelets for in vitro examination of leptospire and platelet binding through microtiter assays 
and fluorescent microscopy. We conclude from these experiments that hemorrhage occurs in 
guinea pigs infected with serovar Pomona and we demonstrate a direct interaction of 
leptospires and platelets in vitro. 
MATERIALS AND METHODS 
Experiment #1 
Animals and experimental design—Guinea pigs (n=30) were housed one per cage at Iowa 
State University in biosafety level-2 rooms maintained at a constant temperature and 
humidity. Cages were cleaned once daily and food and water were available at all times and 
freshened twice daily. Guinea pigs were randomly divided into four groups: controls (n=10) 
and principals inoculated with either 106 (n=5), 107 (n=5), or 108 (n=10) L. interrogans 
serovar Pomona type kennewicki. Inocula consisted of either 1 ml sterile culture media 
(controls) or the appropriate number of leptospires in 1 ml administered into the peritoneal 
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cavity. All animal experiments were performed with the approval of the Iowa State 
University Committee on Animal Care. 
Bacterial strains and growth conditions—L. interrogans serovar Pomona type 
kennewicki strain RM 211 was isolated at the USDA/ARS-National Animal Disease Center 
from neonatal kidney and liver tissues from an Iowa swine herd that were submitted to the 
Veterinary Diagnostic Laboratory at Iowa State University.13 The herd had a history of 25 of 
75 pregnancies resulting in abortion or stillbirth. Leptospires were cultured in Tween 80/40 
semisolid media at 29 C, counted with a Petroff-Hausser Counting Chamber (Hausser 
Scientific, Horsham, PA), and diluted to 108, 107, or 106 organisms per ml in commercial 
Polysorbate Leptospira Medium 5 (PLM 5, Intergen Co., Purchase, NY). Aliquots of 1 ml 
were loaded into syringes for intraperitoneal injection. 
Bacterial colonization—Immunohistochemistry, bacterial culture, or 
immunofluorescence assays were used to confirm bacterial colonization in inoculated guinea 
pigs. Kidney, lung, liver, and heart were examined by immunohistochemistry using a rabbit 
polyclonal antibody to serovar Pomona. Briefly, 5 |j.m sections were cut, placed on 
positively charged slides, and deparafinized with xylene and ethanol by standard procedures. 
Slide mounted tissue sections were rinsed in potassium phosphate buffered solution (KPBS; 
0.15 M NaCl, 0.034 M K2HPO4, 0.017 M KH2PO4, pH 7.4), and antigen retrieval was 
performed by incubating slides for 7 minutes in 37 C KPBS with 0.1% trypsin and 0.1% 
CaClz. After 2 rinses in KPBS, endogenous peroxidase activity was eliminated by incubation 
in 0.3% hydrogen peroxide solution in KPBS for 30 minutes. The sections were then 
incubated for two hours in blocking solution (KPBS with 1% bovine serum albumin, 0.4% 
Triton X-100, and 1.5% normal blocking serum (NBS, donkey; Vector Laboratories Inc., 
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Burlingame, CA 94010), and incubated overnight at room temperature (24°C) in primary 
antiserum. On the following day, tissue sections were rinsed in KPBS with 0.2% Triton X-
100 and incubated in an appropriate biotinylated secondary antibody for two hours at room 
temperature, rinsed, and incubated in Horseradish Peroxidase-Avidin-Biotin Complex 
(Vector Elite ABC Kit; 1:600; Vector Laboratories Inc., Burlingame, CA 94010) for 1 hour 
at room temperature. Enzyme reactions were developed with a substrate kit (NOVA RED, 
Vector Laboratories, Burlingame, CA 94010) producing a red reaction. The reaction was 
terminated in successive rinses of 0.9% NaCl solution. Slides were counterstained with 
hematoxylin, dehydrated through graded alcohols, and coverslipped. 
Samples for blood cultures were taken at necropsy. In addition, liver and kidney 
samples of approximately 1 gram were obtained and processed for isolation of leptospires. 
Three media were used to increase the chances of isolation. First, Tween 80/Tween 
40/lactalbumin hydrolysate was used as previously described14 with slight modifications: 5-
fluorouracil was used at a rate of lOOgg/ml and naladixic acid was not used. Second, 
Ellinghausen-McCullough-Johnson-Harris (EMJH) semisolid media was used as previously 
described 15 with the modifications of 10% BSA, 100 fo.g/ml 5-fluorouracil, and 1% rabbit 
serum. Finally, PLM-5 was used with the addition of purified agar and 100|a,g/ml 5-
fluorouracil. Cultures were incubated at 29° C for 6 months. Darkfield examination was 
performed at 1, 2,4, 6, and 8 weeks and at 3,4, 5, and 6 months. If cultures became 
contaminated, approximately 1 ml was filtered through a 0.22 jxm filter into new medium. 
Representative isolates were identified by restriction endonuclease analysis of chromosomal 
DNA.16 
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Samples of urine, kidney, and liver were stained with fluorescein-labeled rabbit anti-
leptospiral conjugate as previously described.17 Leptospires were identified by typical size, 
morphology, and fluorescence when examined by incident light fluorescence microscopy. 
Necropsy and sample collection—Serial necropsies were done on days 2-6 post 
inoculation (PI). Each day two guinea pigs from the control and 108 groups and one guinea 
pig from each of the 106 and 107 groups were necropsied. Animals were anesthetized using a 
xylazine (10 mg/kg) and ketamine (70 mg/kg). Blood was drawn from the heart for clotting 
assays (PT, PIT, and D-dimer), CBC, and serum biochemistry panels including sodium, 
potassium, chloride, total CO2 (TCO2), calcium, phosphorus, blood urea nitrogen, creatinine, 
glucose, total protein, albumin, alanine aminotransferase (ALT), alkaline phosphatase (ALP), 
y-glutamyltransferase (GGT), creatine kinase (CK), direct bilirubin (Dbili), total bilirubin 
(Tbili), and anion gap. During necropsy, liver, kidney, and urine were taken aseptically for 
culture and immunofluorescence testing. Samples of kidney, liver, lung, hepatic lymph node, 
adrenal gland, spleen, heart, pancreas, stomach, small intestine, cecum, colon, bladder, bone 
marrow, and thymus gland were collected into 10% neutral buffered formalin. 
Histopathology—Samples were placed in 10% neutral buffered formalin for 24 
hours, then embedded in paraffin, sectioned at 5 (am (3 jam for kidney, spleen, lymph node, 
and bone marrow), mounted on glass slides and stained with hematoxylin and eosin (H&E) 
according to standard histologic procedures. 
Experiment #2 
Animals—All animal protocols were approved by the Iowa State University 
Committee on Animal Care. Blood was collected from female guinea pigs (n=8) weighing 
250 to 400g. Guinea pigs were anesthetized with 10 mg/kg xylazine in combination with 70 
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mg/kg ketamine injected IP, and 9 volumes blood were drawn with a 22-guage needle from 
the heart into tubes containing 1 volume 0.105 M sodium citrate. After obtaining 12-15 ml 
of blood, the animals were euthanized. 
Preparation of Gel Filtered Platelets—Blood with sodium citrate anticoagulant was 
transferred into polypropylene tubes, and centrifuged for 15 min. at 140 x g to obtain platelet 
rich plasma (PRP). The PRP was filtered through an agarose bead column18 (Sepharose 2 B 
Sigma, St. Louis, MO) equilibrated with modified HEPES-Tyrode's buffer (2 mM HEPES, 
137 mM NaCl, 12mM NaHCOs, ImM MgCla, 2.7 mM KCL, 5.6 mM dextrose, 0.35% 
bovine albumin at pH 7.35), and adjusted to flow at approximately 1 ml/min. Platelet 
fractions were adjusted to 108/ml and activated with 0.2 U/ml thrombin (Sigma Chemical, St. 
Louis, MO) for 20 minutes at room temperature. Platelet poor plasma (PPP) was obtained by 
centrifuging the remaining sample at 1800 x g for 15 minutes. 
Preparation of bacteria—L. interrogans serovar Pomona type kennewicki strain 
RM211 was grown in BAP-80 liquid medium19 or PLM-5 at 29 C. Approximately 14 ml of 
active liquid culture media was divided into 1 ml portions in microcentrifuge tubes and 
centrifuged at 14,000 g for 8 minutes. The supernatant was poured off, and the pellet was 
resuspended in PBS and centrifuged again at 14,000 g for 8 minutes. The supernatant was 
removed and the pellet resuspended in a mixture of 2:1 BAP-80 medium to PBS, serial 
dilutions performed, and the bacteria were counted using a Petroff-Hausser Counting 
Chamber. A 109 leptospire/ml concentration was used for the slide preparations and a 108 
leptospire/ml dilution was used for the microtiter assays. 
Microliter assays of platelet-leptospire binding—Platelet-spirochete binding was 
assessed in an assay similar to that previously described7 using fluorescent DNA staining to 
detect bound leptospires, since platelets are anuclear and devoid of DNA. Activated platelets 
(107 per well) were added to black polystyrene micro titer plates (Cliniplate, Thermo-
Labsystems; Fisher Scientific, Hanover Park, IL) and centrifuged at room temperature for 15 
min at 425 x g. Platelet monolayers were covered with approximately 5 x 106 leptospires and 
centrifuged at 1,200 x g for 20 minutes to facilitate leptospire-platelet contact. A 30 min 
incubation at room temperature allowed for stable binding of bacteria. Unbound bacteria 
were removed by washing three times with PBS. Bound spirochetes and platelets were fixed 
by addition of 3% paraformaldehyde in PBS (50 jo.1 per well). The paraformaldehyde was 
allowed to dry overnight at room temperature, and the cells were permeabilized by 
incubating the cells for 10 min at -20 C in 50ja,l/well prechilled methanol. After the 
methanol was removed, plates were allowed to dry at room temperature. The fluorescent 
DNA stain 4',6-diamidino-2-phenylindole (DAPI; Molecular Probes, Eugene, OR) was used 
at 0.1 j^g/ml in PBS with 50 /Ltl added to each well, and the plates incubated for 10 min at 
room temperature in the dark. After two washes in PBS and addition of 50 pi of fresh PBS 
per well, fluorescence was quantitated by a microplate spectrofluorometer (SPECTRAmax 
GEMINI XS, Molecular Devices Corporation, Sunnyvale CA) at an excitation wavelength 
of 355 nm and an emission wavelength of 460 nm. Fluorescence of leptospire only wells 
was compared to that of platelet monolayers with an equal number of applied leptospires 
alone or after incubation with various potential binding inhibitors. Attempts to inhibit 
platelet-leptospire binding were made with anti-CD41a (P2 Clone, Beckman Coulter, Miami, 
FL), a function blocking antibody that reacts with the cdlb subunit of the intact integrin 
oHbfo, and 5 mM EDTA, a non-specific integrin blocker. In addition, leptospires were 
incubated in dextran sulfate to block sites for cell membrane proteoglycan binding8 or 
gelatin to block fibronectin binding sites.20 PPP and 70 /tg/well fibrinogen were used as 
controls for non-specific protein binding. All assays were performed in triplicate on platelets 
derived from three or more guinea pigs. 
Microscopy—Samples for fluorescent microscopy were prepared by placing 100 /il 
containing 1 x 107 platelets or 1 x 107 activated platelets and 100fû containing 1 x 108 
leptospires in a microcentrifuge tube. After a 20 min incubation at room temperature, 
samples were fixed by adding 100 /-d of a 2% glutaraldehyde and 2% paraformaldehyde 
solution. Ten pd of the sample was used for smears on polylysine coated slides for 
fluorescent microscopy. Air dried slides were rinsed with PBS and incubated in blocking 
solution for 90 minutes (PBS with 5% Donkey serum (Jackson ImmunoResearch, West 
Grove, PA, USA 19390) at room temperature. Slides were subsequently incubated in anti-
CD41(P2 Clone, Beckman Coulter, Miami, FL 33196; 1:200) diluted in blocking solution for 
12 hours at room temperature. After incubation in primary antibody, slides were rinsed in 
PBS and incubated in secondary antibody for 90 minutes at room temperature (Donkey anti-
mouse IgG-Alexa 488,1:200; Molecular Probes, Eugene, OR). After rinsing in PBS, slides 
were incubated in DAPI (Molecular Probes, Eugene, OR; 0.1 /ig/ml PBS) rinsed in PBS and 
coverslipped with Vectashield mounting medium (Vector Laboratories, Burlingame, CA). 
Alexa 488 and DAPI fluorescence was viewed with a Nikon ES800 microscope equipped 
with fluorescence detection. Images were captured with a Retiga 1300 CCD camera driven 
by Open Lab Software (Improvision). 
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RESULTS 
Experiment 1 
Confirmation of infection and biochemical, gross, and histopathologic lesions— 
The presence of leptospires was confirmed in all inoculated guinea pigs by culture, 
immunohistochemistry, or immunofluorescence testing (data not shown). No clinical signs 
were noted in any inoculated guinea pigs, but average weight gain was less in inoculated 
animals (106 (50.5g), 107(24g), 108(27.5g)) when compared to controls (71g). On days 3-6 
PI the infected group had a lower average platelet count than the control group (Fig. 1). 
Figure 1. At days 3 and 4 PI, there is a transient decrease in the platelet count of inoculated 
guinea pigs when compared to control. 
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No other significant differences were noted in CBC or serum biochemistry results from 
inoculated guinea pigs. Beginning at day 3 PI, infected guinea pigs had gross lesions 
including multifocal 1-2 mm slightly raised, round white foci throughout the liver (hepatic 
necrosis (13/16)), splenomegaly (8/16), and pulmonary hemorrhage (8/16) (Fig 2). 
FIGURE LEGENDS 
Figure 2- Gross image of the lungs of a Leptospira interrogans serovar Pomona strain RM 
211 inoculated guinea pig at 3 days PL There are multifocal to coalescing pulmonary 
hemorrhages. 
Figure 3- Photomicrograph of a section of lung from a serovar Pomona inoculated guinea pig 
at 3 days PL Multiple alveoli are filled with blood. H&E stain. Bar = 50 jtmi 
Figure 4- Photomicrograph of a section of heart from a serovar Pomona inoculated guinea 
pig at 3 days PL Cardiac myocytes are widely separated by blood and are multifocally 
necrotic. Inset: Necrotic cardiac myocytes are swollen and pale and lack cross striations. 
H&E stain. Bar =100 jum; Inset=3O fim 
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No histologic lesions were noted in guinea pigs at day 2 PL In guinea pigs examined on 
days 3-6 PI, hemorrhages were present in lung (12/16) (Fig. 3), kidney (6/16), heart (10/16) 
(Fig. 4), and sporadically in pancreas, adrenal gland, lymph node, meninges, and perirenal 
adipose tissue of infected guinea pigs. Hemorrhage in lymph nodes and lung was associated 
with phagocytosis of erythrocytes by macrophages (erythrophagocytosis). Mixed 
inflammatory infiltrates of lymphocytes, macrophages, plasma cells, and neutrophils 
occurred in the renal cortical interstitium and pelvis and sporadically in interlobular and 
perivascular areas of the pancreas and within the heart. Interstitial nephritis was subtle 
except for day 6 PI where interstitial infiltrates were associated with lesions in adjacent 
tubules, including flattened tubular epithelium with occasional apoptotic cells. Lesions in the 
liver included portal infiltrates of lymphocytes and neutrophils (11/20), and random 
multifocal areas of hepatic coagulative necrosis (15/20). The enlargement of the spleen in 
several guinea pigs was associated with lymphoid hyperplasia, congestion, and hemorrhage. 
Experiment 2 
Microliter binding assays and fluorescent microscopy—After the addition of a 
known number of leptospires, fluorescence levels of DAPI stained microtiter wells were 
measured (Fig. 4). When leptospires were applied directly to empty wells or wells 
containing fibrinogen or platelet poor plasma, fluorescence levels were similar to wells 
containing only buffer. When leptospires were applied to platelet monolayers fluorescence 
levels were markedly increased. Fluorescent levels were similar after incubation of platelets 
with anti CD41 antibody or EDTA (data not shown),or incubation of leptospires with gelatin 
or dextran sulfate. 
FIGURE LEGEND 
Figure 5-Images from right to left illustrate CD41 fluorescence for platelet integrin 
cdIb/?3, DAPI fluorescence of leptospiral DNA, and an overlay image, respectively. In 
non-activated platelet samples (top row), platelets are singular without apparent 
association with leptospires. In activated platelet samples (bottom row), platelets and 
leptospires form large aggregates. 
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Figure 4. The fluorescence intensity of DAPI stained leptospiral DNA is plotted for wells 
containing no substrate; activated platelets only; activated platelets treated with anti-CD41, 
an integrin allbft blocker; and fibrinogen, a control for non-specific protein binding. 
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By fluorescent microscopy, large numbers of leptospires were present around individual 
activated platelets or surrounding and within larger platelet aggregates (Fig 5). These 
aggregates did not occur in samples with non-activated platelets. 
DISCUSSION 
Guinea pig inoculations and in vitro binding assays were done to assess the extent of 
hemorrhagic lesions in a guinea pig model of Leptospira interrogans serovar Pomona 
infection and to test the hypothesis that leptospires can bind platelets. Inoculation of guinea 
pigs with serovar Pomona causes hemorrhagic and inflammatory lesions in a variety of 
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tissues. In vitro binding assays showed enhanced binding of leptospires to microtiter wells 
with platelet monolayers when compared to binding of leptospires to wells without platelets 
or wells containing platelet poor plasma or fibrinogen. Fluorescence microscopy was used to 
further demonstrate leptospire binding of platelets. 
Serovar Pomona in guinea pigs caused mild interstitial nephritis, hepatic necrosis, and 
inflammation in hepatic portal areas. Lesions were not associated with serum biochemical 
abnormalities, increased PTT or PT, or significant D-dimer titers. Platelet numbers in the 
infected group were mildly decreased days 3-6 PI, relative to the control group (Fig. 1). The 
decrease in platelet numbers corresponded with the appearance of hemorrhage. Although 
platelet numbers remained adequate for appropriate hemostasis, platelet functional ability is 
unknown. 
Leptospires interacted with activated platelets as shown by leptospire binding to 
platelet monolayers. In contrast to Borrelia, significant blocking of binding did not occur 
after incubating the activated platelets with integrin cdlbft blocking antibody, EDTA,6,7 or 
incubating the leptospires in buffer containing dextran sulfate.8 Gelatin blocks binding sites 
of fibronectin,20 a component of platelet a granules, but binding of leptospires to platelet 
monolayers was not inhibited by incubation with gelatin. These data suggest that platelet 
leptospire interactions are not mediated by binding through integrins or fibronectin, but 
multiple concentration studies were not done. Fluorescent microscopy was used to view 
contacts that platelets and leptospires make when incubated in vitro. When leptospires 
interact with activated platelets, clumping occurs and aggregates of leptospires and platelets 
form. The binding studies in this work suggest this is not integrin aJIbft mediated. 
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There are several possible roles for direct interactions between platelets and 
leptospires in the pathogenesis of leptospirosis. First, leptospire binding to platelets could 
result in decreased platelet function via platelet clumping or covering surface receptors. This 
mechanism could be an important factor in leptospire induced hemorrhage. Second, binding 
of leptospires to platelets may facilitate infection by transporting leptospires to areas of 
endothelial damage, which may promote entry of leptospires into organ parenchyma. Also, 
in areas of platelet activation and endothelial damage bacterial binding to platelets adherent 
to the subendothelium may facilitate leptospire infiltration. Finally, clumps of platelets 
around individual or groups of leptospires could shield the bacteria from the immune system 
and allow spread of infection. Infectious strains of Borrelia burgdorferi bind platelets 
whereas noninfectious strains do not,7 but experiments have not been done to determine 
binding properties of other pathogenic and saprophytic isolates of Leptospira. 
Hemorrhagic lesions occur in guinea pigs experimentally inoculated with Leptospira 
interrogans serovar Pomona. In the absence of abnormal PT, PTT, and D-dimer assays, a 
potential pathogenesis for hemorrhage may involve platelet-endothelial-leptospire 
interaction. We have demonstrated that leptospires bind activated platelets in vitro. Further 
studies are needed to determine the specific mechanism of binding and quantitate the extent 
of binding in vivo. 
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CHAPTER 5. GENERAL CONCLUSIONS 
The purpose of the studies contained in this dissertation was to better understand the 
clinical and pathologic abnormalities caused by infections with Leptospira kirschneri serovar 
Grippotyphosa and Leptospira interrogans serovars Pomona and Bratislava. Dogs were 
inoculated with all serovars and additional studies were done with serovar Pomona in guinea 
pigs. The guinea pig model was used to study binding of leptospires to platelets in vitro. 
In the first study, "Clinical and pathologic comparison of acute canine leptospirosis 
caused by two strains of Leptospira kirschneri serovar Grippotyphosa", it was demonstrated 
that infection with serovar Grippotyphosa causes severe renal and hepatic failure. 
Biochemistry profiles were consistent with severe renal and hepatic insufficiency, and 
infected dogs had lesions in kidney, liver, and pancreas. The predominant renal lesions 
consisted of interstitial nephritis, tubular degeneration and necrosis, and tubular 
mineralization. Early hepatic lesions consisted of portal and perivascular infiltrates of 
lymphocytes and plasma cells. Dogs necropsied later had evidence of severe cholestasis: 
dissociation of hepatocytes from hepatic laminae, hepatic lipidosis, and bile plugs in bile 
canaliculi. Lesions are similar in dogs infected with strain 82, a canine derived isolate, and 
strain RM 52, a swine derived isolate. However, strain 82 caused disease in a greater number 
of dogs. Infections were confirmed in 11/12 strain 82 inoculated dogs; whereas, only 3/14 
strain RM 52 inoculated dogs were confirmed to be infected. 
In the second study, "Experimental canine leptospirosis caused by Leptospira 
interrogans serovars Pomona and Bratislava", the disease model established in the first study 
was used to investigate two additional serovars of Leptospira. The serovar Bratislava isolate 
was obtained from a canine source,1 but did not cause disease in dogs or hamsters in an 
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experimental setting. The swine derived isolate of serovar Pomona caused lethargy, fever, 
and diarrhea in infected dogs and was associated with inflammation and hemorrhage in dogs 
necropsied at days 10,14, and 20 post-inoculation (PI). Hemorrhage occurred in kidney and 
lung and was most severe at 10 days PI. In some cases, interstitial infiltrates progressed to 
affecting 25-50% of the parenchyma at 20 days PI. As compared to serovar Grippotyphosa; 
however, there were no biochemical abnormalities suggestive of renal failure. Elevated BUN 
in the absence of elevated creatinine occurred in 2 cases, which suggests hemorrhage into the 
intestine and resorption of blood. Liver lesions in serovar Pomona infected dogs were 
consistent with cholestasis at 20 days PI, which was corroborated by markedly elevated 
hepatic enzymes (ALP and GGT). Similar to serovar Grippotyphosa, pancreatitis occurred in 
a lesser number of cases, which has been described as a manifestation of serovar Pomona in a 
pork abattoir worker.2 Platelet counts were decreased in infected dogs when compared to 
controls, and a subset of samples was used to perform platelet aggregation studies. In 
infected dogs coagulation assays (PT, PTT, and D-dimer) remained within normal reference 
intervals, but platelet aggregation curves were blunted suggesting a decrease in platelet 
function. A platelet functional defect was suspected, but the mechanism of the defect could 
not be determined. 
There are a number of ways that platelet function could be affected during 
leptospirosis. Spirochetes in the genus Borrelia have been shown to bind platelets directly,3"6 
so similar assays were done with Leptospira interrogans serovar Pomona. The third 
manuscript, "Leptospira interrogans serovar Pomona infection in guinea pigs and in vitro 
evidence of leptospire binding of platelets", demonstrates hemorrhage in a guinea pig model 
of serovar Pomona infection and provides in vitro evidence of platelet leptospire binding. 
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Hemorrhage was temporally correlated with a decrease in platelet count similar to the canine 
model. Microtiter assays show that leptospires bind to platelet monolayers, but do not bind 
to wells without platelets or wells containing platelet poor plasma or fibrinogen. When 
activated platelets and leptospires are incubated and fluorescent stained, large aggregates 
form. Incubation of leptospires with non-activated platelets does not result in the formation 
of aggregates. Binding was not inhibited with anti- integrin oIIb/33 antibody as it is in 
Borrelia. 4 
The canine studies reported in this dissertation are important foundation work for 
further study of the pathogenesis of canine leptospirosis and the development of treatment 
and prevention strategies. "Clinical and pathologic comparison of acute canine leptospirosis 
caused by two strains of Leptospira kirschneri serovar Grippotyphosa" is the first published 
experimental study of disease caused by serovar Grippotyphosa after mucous membrane 
(conjunctival) exposure. Previous experimental models of canine leptospirosis have used 
subcutaneous, intraperitoneal, intramuscular, or intravenous inoculation techniques rather 
than a natural route of exposure. This model of mucous membrane inoculation more closely 
assimilates natural disease, so the incubation period, clinical signs, gross and histologic 
lesions, immune responses, and serum biochemical alterations produced through the use of 
this model should be similar to that in natural disease making it the model of choice for 
experimental studies and testing treatment regimens and disease prevention strategies such as 
vaccines. 
A number of other studies could directly follow this work. An ultrastructural study 
comparing renal lesions caused by serovars Grippotyphosa and Pomona is indicated since 
lesions detected by light microscopy did not correlate well with parameters measuring organ 
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function. Renal inflammation is much more severe in serovar Pomona infected dogs than 
those infected with serovar Grippotyphosa, but biochemical abnormalities suggest renal 
failure in only the latter. In addition, this model of canine infection could be used in the 
future to test additional serovars emerging in the canine population or to test antibiotic 
protocols. Our research group has already used this model of canine leptospirosis using 
conjunctival inoculation to test the efficacy of whole-cell leptospiral vaccines. Dogs were 
vaccinated at 9 and 11 weeks with a 1 ml containing 1 x 109 thimerosal killed leptospires. 
Three weeks after the second vaccination, dogs were challenged with serovar Grippotyphosa 
via the conjunctiva. Control (non-vaccinated) dogs had clinical signs, histologic lesions, and 
biochemical abnormalities to those described in "Clinical and pathologic comparison of acute 
canine leptospirosis caused by two strains of Leptospira kirschneri serovar Grippotyphosa", 
but vaccinated dogs were protected from clinical disease. 
There are several reasons to study leptospirosis in a guinea pig model. Guinea pigs 
are less expensive, more uniform in condition, and easier and less dangerous to restrain than 
dogs. As opposed to smaller laboratory animals, guinea pigs are large enough for small 
repeated blood samples or large single sampling for multiple tests at necropsy. Further 
studies should address the function of platelets in Leptospira infected guinea pigs, and the 
function of platelets after exposure to live or attenuated leptospires and extracted leptospiral 
lipoproteins or LPS. Specific mechanisms of leptospire binding of platelets need to be 
examined further through a more extensive panel of potential inhibitors. Integrin cdlbft was 
a good candidate for initial studies because it is the most abundant receptor on the platelet 
surface, but blocking antibodies did not result in the inhibition of binding. Testing of 
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additional inhibitors was limited by the volume of platelets that can be obtained for study at 
one time and the availability of reagents with guinea pig specificity. 
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APPENDIX. PRELIMINARY PLATELET FUNCTION STUDIES IN 
SEROVAR POMONA INFECTED DOGS 
Leptospira interrogans serovar Pomona infected dogs hemorrhage into the lungs, 
kidneys, and gastrointestinal tract, but assays of clotting factors (PTT, PT) and fibrinolysis 
(D-dimer) fail to detect abnormalities in these dogs. Platelet numbers in affected dogs were 
decreased from baseline values at day 10 post inoculation (PI), but were considered adequate 
for hemostasis. Platelet dysfunction as a cause of hemorrhage in acute leptospirosis has not 
been previously studied, so platelet aggregation assays were done on a subset of infected 
animals to test the hypothesis that platelet function is altered in dogs infected with serovar 
Pomona. 
A platelet aggregometer was used to assess the platelets' contribution to hemostasis in 
vitro. Control dog aggregation responses were compared to those of animals with clinical 
disease through the use of optical and impedance aggregometry methods. Optical platelet 
aggregometry measures changes in optical density of platelet rich plasma with a standardized 
platelet count whereas impedance aggregometry measures the change in resistance on an 
electrode caused by formation of a platelet plug in a sample of whole blood. Aggregation is 
measured after the addition of a strong agonist such as collagen or thrombin. The addition of 
a soluble agonist to a stirred platelet suspension induces activation of integrin 
converting it from a low to high-affinity receptor capable of binding soluble fibrinogen, an 
abundant plasma protein. Fibrinogen cross-links adjacent activated platelets leading to stable 
platelet aggregation, which is measured as a change in light transmittance or electrical 
impedance in optical or impedance aggregometry, respectively. 
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Blood was collected from a healthy control dog and two serovar Pomona inoculated 
dogs for platelet aggregometry. Using a 22 gauge needle, 9 volumes whole blood were 
drawn into tubes containing 1 volume 0.105 M sodium citrate. For impedance aggregometry, 
1 ml of blood was diluted with 1ml of 0.9% NaCl before samples were run in duplicate on a 
platelet aggregometer (Chronolog 530-VS, Chronolog Corp., Havertown, PA). Additional 
steps were required to use the optical method. Blood with sodium citrate anticoagulant was 
transferred into polypropylene tubes, and centrifuged for at 1300 x g for three intervals of 90 
seconds to obtain platelet rich plasma (PRP). PRP was gathered in a separate polypropylene 
tube after each interval of centrifugation. Platelet counts were done on PRP using a Petroff-
Hausser counting chamber and 250 pi samples of PRP with approximately 2.5 x 105/ ml were 
used in the optical aggregometry studies. After PRP was obtained, the remaining 
constituents of the original sample were centrifuged at 1800 x g for 10 minutes to obtain 
platelet poor plasma (PPP) to use as an optical density standard representing 100% platelet 
Figure 1. Platelet aggregation measured by impedance aggregometry was decreased in 
infected animals at 19 days post inoculation. The aggregation curve of an infected dog at 19 
days post inoculation is blunted when compared to a control with a similar platelet count. 
control serovar Pomona 
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aggregation. Readings were obtained in duplicate for 7-14 minutes after the addition of 4 pi 
of 1 mg/ml collagen as an agonist. Aggregation curves from infected dogs were compared to 
curves obtained from control dogs. 
Preliminary results suggest that platelet function as measured by the platelet 
aggregation response is decreased in dogs infected with serovar Pomona. Altered platelet 
function in serovar Pomona infection would result in defective platelet plug formation and 
hemorrhage at the sites of endothelial damage. To better understand platelet function in 
leptospirosis additional platelet aggregometry studies should be done at 10 days post-
inoculation using the canine model of serovar Pomona infection as that is when the most 
severe clinical hemorrhage occurs. Since platelet numbers are decreased in infected dogs 
during that time period, it will be necessary to perform optical aggregometry on samples of a 
standardized platelet count, so platelet aggregation can be compared between samples 
without interpretation being complicated by any difference in platelet numbers between 
animals. In addition, platelet aggregation should be assayed in samples obtained from 
control dogs and incubated with live leptospires or leptospiral extracts. A complete study 
comparing platelet aggregation of infected animals to platelets incubated in vitro with live 
leptospires will help determine whether altered platelet function is a direct effect of live 
leptospires, or occurs as a result of altered biochemical parameters in diseased animals. 
